Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1050.Time spend outdoors in summer,49767,-0.0377093831982119,0.0360965927788404,-0.108458705044739,0.0330399386483153,0.296182890479365
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1060.Time spent outdoors in winter,47620,-0.00801141496826971,0.0407246100022697,-0.0878316505727184,0.071808820636179,0.844047420964958
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1070.Time spent watching television (TV),50555,0.0379266816186254,0.0364983012367133,-0.0336099888053327,0.109463352042583,0.298753152593319
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1080.Time spent using computer,47631,-0.00454887853376805,0.0374409743217531,-0.0779331882044041,0.068835431136868,0.903300524990011
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1090.Time spent driving,44963,-0.0492372117847846,0.0418192375422059,-0.131202917367508,0.0327284937979389,0.239060251641194
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1160.Sleep duration,51603,-0.00730640342398724,0.033534136711406,-0.0730333113783429,0.0584205045303684,0.827524875044686
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35859,-0.00059414603596681,0.0137187652185416,-0.0274829258643084,0.0262946337923748,0.965456406257053
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35859,-0.00270384127856981,0.015187657539692,-0.0324716500563661,0.0270639674992265,0.858705282561379
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35859,0.013838085533785,0.0160344041381533,-0.0175893465769954,0.0452655176445655,0.388152442842467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35859,0.00196964429104431,0.0164090638438969,-0.0301921208429935,0.0341314094250822,0.904459598153183
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35859,-0.0118433639299756,0.0168634164007768,-0.0448956600754983,0.021208932215547,0.482507713136614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35859,0.0907739552902183,0.0441807503600004,0.00417968458461751,0.177368225995819,0.0399529678139345
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35859,0.0809944572324883,0.0528813516470561,-0.0226529919957416,0.184641906460718,0.125658310128898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35859,0.0262252056132091,0.0266479977554743,-0.0260048699875205,0.0784552812139388,0.325082339347725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35859,0.00946077998473199,0.0206261157993028,-0.0309664069819015,0.0498879669513655,0.646477947731644
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35859,-0.00376561882695501,0.0138104911504509,-0.0308341814818388,0.0233029438279288,0.785119540543726
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35859,0.011140037497843,0.0217933852428752,-0.0315749975781924,0.0538550725738784,0.609250372681008
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35859,-0.00739372544541057,0.010283085003564,-0.0275485720523959,0.0127611211615748,0.472152840056642
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35859,-0.00481771907392808,0.0141193878602588,-0.0324917192800353,0.0228562811321791,0.732953092596451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35859,0.0161514961279089,0.0223651317919084,-0.0276841621842316,0.0599871544400494,0.470211334424291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35859,-0.00116674051405695,0.0209839750503036,-0.0422953316126519,0.039961850584538,0.95566079877957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35859,0.0146799639038407,0.0254941287551267,-0.0352885284562076,0.064648456263889,0.564756435696912
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35859,-0.00657315621733734,0.0249305040846658,-0.0554369442232823,0.0422906317886076,0.792050037783704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35859,0.00632622111518635,0.0157015281500516,-0.0244487740589148,0.0371012162892875,0.687030122695054
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35859,0.0212540303422398,0.015382336280627,-0.00889534876778914,0.0514034094522687,0.167101237668285
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35859,-0.00926681015278465,0.0170810663042868,-0.0427457001091868,0.0242120798036175,0.587477389026876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120040.Fatigue severity over the past week,35866,0.00975406060683589,0.0632350321223216,-0.114186602352914,0.133694723566586,0.877416195305861
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120041.Waking unrefreshed severity over the past week,35869,-0.0185554738568956,0.0620513953920188,-0.140176208825253,0.103065261111461,0.764922692796504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120042.Cognitive symptoms severity over the past week,35868,-0.00213256895366071,0.0696181725088863,-0.138584187071078,0.134319049163757,0.975563575671644
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120098.Mobility problems today,35870,0.0224176972810031,0.0732676870706434,-0.121186969377458,0.166022363939464,0.759636428143717
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120099.Self-care problems today,35870,0.0681134329302117,0.108748354496244,-0.145033341882426,0.281260207742849,0.531111697036688
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120100.Problems doing usual activities,35870,0.0592839627638137,0.0694964925996149,-0.0769291627314315,0.195497088259059,0.393659853662325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120101.Pain or discomfort today,35870,0.0782157714612447,0.0616111741479909,-0.0425421298688174,0.198973672791307,0.204301211249408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120102.Anxiety or depression today,35870,-0.0147016153531206,0.082866528954285,-0.177120012103519,0.147716781397278,0.859188791076438
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120103.Scale to indicate how health is today,35853,-0.00318311837534309,0.00449514375928681,-0.0119936001435452,0.00562736339285905,0.478891123123602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35854,0.00337148058070281,0.0789071435140542,-0.151286520706843,0.158029481868249,0.965920180481191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35852,0.0398423412570309,0.0824130847030237,-0.121687304760896,0.201371987274957,0.628793132047436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35858,0.0181529967268741,0.0629849961179025,-0.105297595664215,0.141603589117963,0.773193120660643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35863,0.0604183761259362,0.063730599636486,-0.0644935991615764,0.185330351413449,0.343146883971858
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35862,0.143690922642921,0.0883221171099411,-0.0294204268925639,0.316802272178405,0.103802528346788
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120109.Feeling bad about self over the last two weeks,35845,-0.034062290573897,0.0927042081456885,-0.215762538539446,0.147637957391653,0.713309166307687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120110.Trouble concentrating over the last two weeks,35865,-0.00784119089070526,0.0848670165384266,-0.174180543306021,0.158498161524611,0.926387669110952
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35858,0.0334317926495819,0.121672210381888,-0.205045739698919,0.271909324998082,0.783501279477897
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35825,-0.128040976174435,0.190497707478014,-0.501416482831342,0.245334530482471,0.501516583314315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33106,0.0342121080278824,0.0880640987297907,-0.138393525482507,0.206817741538272,0.697671089910459
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49135,-0.0958493034288502,0.0910733751427573,-0.274353118708654,0.0826545118509541,0.292609905324477
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47941,-0.0329631960340949,0.0487081739918102,-0.128431217058043,0.062504824989853,0.498573471549184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1289.Cooked vegetable intake,50687,-0.00472853314993338,0.0348996151559566,-0.0731317788556082,0.0636747125557415,0.892226060779321
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49871,0.0245300600924771,0.0358057938920283,-0.0456492959358984,0.0947094161208526,0.493296908543883
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1309.Fresh fruit intake,50544,0.00912166623010004,0.0365214447502468,-0.0624603654803836,0.0807036979405837,0.802773806547374
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1319.Dried fruit intake,49573,0.0165417921960237,0.0389686246963823,-0.0598367122088856,0.0929202966009329,0.67121283806164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X134.Number of self-reported cancers,51749,-0.0243470234405692,0.0750792771501568,-0.171502406654877,0.122808359773738,0.745725809690656
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X135.Number of self-reported non-cancer illnesses,51750,-0.0568642373839691,0.0340033075545549,-0.123510720190897,0.0097822454229585,0.0944757597907191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X136.Number of operations, self-reported",51750,-0.00951716634838075,0.0336985032788607,-0.0755662327749478,0.0565319000781863,0.777623208580644
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X137.Number of treatments or medications taken,51750,-0.0535031944796277,0.0334986027641604,-0.119160455897382,0.0121540669381266,0.11023992985849
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1438.Bread intake,51210,-0.00203181266584165,0.00250454033361042,-0.00694071171971807,0.00287708638803478,0.417229666497398
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1458.Cereal intake,50570,-0.0158278026331977,0.034763682823207,-0.0839646209666835,0.0523090157002881,0.648900039531929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1488.Tea intake,50889,0.00339433674012856,0.00246988231814079,-0.00144663260342738,0.0082353060836845,0.169365214921206
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1498.Coffee intake,49958,-0.0194918901738353,0.034216136838248,-0.0865555183768014,0.0475717380291307,0.568907859991099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1528.Water intake,49641,0.0625312529460644,0.0351563341910509,-0.00637516206839549,0.131437667960524,0.0753095475047403
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1568.Average weekly red wine intake,46230,0.0698410988191915,0.0376739479437691,-0.00399983915059603,0.143682036788979,0.063780162607922
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46222,0.0447574631610076,0.0388224772028343,-0.0313345921565477,0.120849518478563,0.248977336061165
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1588.Average weekly beer plus cider intake,46293,0.0060140900029786,0.0394689453274195,-0.0713450428387637,0.0833732228447209,0.878892722484387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1598.Average weekly spirits intake,46219,-0.0268421585487232,0.0402186113192881,-0.105670636734528,0.0519863196370815,0.504521321122513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1608.Average weekly fortified wine intake,46261,0.024520685910825,0.0718738684322226,-0.116352096216331,0.165393468037981,0.732985130043499
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1737.Childhood sunburn occasions,45638,-0.0133149164544659,0.0400788907301907,-0.0918695422856397,0.065239709376708,0.739728974752597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1807.Father's age at death,45831,-0.0033041478417387,0.00281747146656341,-0.00882639191620298,0.00221809623272558,0.240918240470288
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1845.Mother's age,37113,-0.00505245866293905,0.00683017438896914,-0.0184396004653186,0.00833468313944047,0.459486570003899
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1873.Number of full brothers,51351,-0.0310396161812855,0.032941793677387,-0.0956055317889641,0.033526299426393,0.346071385955144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1883.Number of full sisters,51353,-0.0060820019256266,0.0327712403569838,-0.0703136330253149,0.0581496291740617,0.852768251435679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20015.Sitting height,51545,-0.00041321645920005,0.00322562560617584,-0.00673544264730469,0.00590900972890459,0.898067568415532
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20016.Fluid intelligence score,35991,-0.0378940765302906,0.0590522129287307,-0.153636413870603,0.0778482608100215,0.5210849358505
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20018.Prospective memory result,36331,0.117232398435635,0.0709573576315007,-0.021844022522106,0.256308819393377,0.0985440163785971
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35908,-0.0101448502361095,0.00435176957482519,-0.0186743186027668,-0.00161538186945208,0.0197698065773658
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35912,-0.00130128739124705,0.00431210451865762,-0.00975301224781599,0.00715043746532189,0.762831809709479
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20023.Mean time to correctly identify matches,51443,-0.000311183746950322,0.00252666376728325,-0.00526344473082549,0.00464107723692484,0.901981534228059
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#1.Illnesses of father_Heart disease,48373,0.000981130046766849,0.00566642169301626,-0.010125056471545,0.0120873165650787,0.862536804179528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47929,0.00256321909866216,0.0127885699726229,-0.0225023780476787,0.0276288162450031,0.841146039506105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47891,0.00469559525890157,0.0168334869752232,-0.028298039212536,0.0376892297303391,0.780291015955087
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#12.Illnesses of father_Severe depression,47914,0.0278079693352203,0.0151453531427878,-0.00187692282464378,0.0574928614950844,0.0663622686653186
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47934,-0.00700976064298143,0.0100712719593881,-0.026749453683382,0.0127299323974192,0.486427535657549
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#2.Illnesses of father_Stroke,48106,-0.00484409268642516,0.00724275475983793,-0.0190398920157075,0.00935170664285719,0.503618799152412
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48056,-0.00395077119978482,0.00923599823177534,-0.0220533277340645,0.0141517853344948,0.668832125858208
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47950,-0.00859672719792308,0.0111991372543719,-0.0305470362164921,0.0133535818206459,0.442719931143311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48076,-0.00704186332041772,0.00859246516017699,-0.0238830950343646,0.00979936839352919,0.412488788895971
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48164,-0.00209521002642077,0.00642557516377989,-0.0146893373474293,0.0104989172945878,0.74437220516314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#9.Illnesses of father_Diabetes,48025,-0.00161051505081021,0.00883857705093132,-0.0189341260706356,0.0157130959690152,0.855416459542995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49130,-0.00479072377261519,0.00667131269685784,-0.0178664966584566,0.00828504911322618,0.472698799683771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,48972,-0.00157083539284882,0.00937569487465329,-0.0199471973471693,0.0168055265614716,0.86694419874996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,48895,0.00182791494285738,0.02068043126738,-0.0387057303412074,0.0423615602269222,0.929568671692253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#12.Illnesses of mother_Severe depression,48928,0.00152051544742403,0.0111187959903713,-0.0202723246937036,0.0233133555885517,0.891228332062941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#2.Illnesses of mother_Stroke,49071,0.00325195774769863,0.00747186277858523,-0.0113928932983284,0.0178968087937257,0.663402125841432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,48969,-0.0285866132010819,0.0124916086309549,-0.0530701661177536,-0.00410306028441019,0.0221206289773278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,48934,-0.003023216216417,0.0113874124877693,-0.0253425446924448,0.0192961122596108,0.790636592633959
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,48945,0.0198910616208153,0.00951754093931964,0.00123668137974882,0.0385454418618818,0.0366358383758427
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,48981,0.00724885898988555,0.0113970769290173,-0.0150894117909883,0.0295871297707594,0.524765374461159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49180,0.0018653194075207,0.00572771763172084,-0.00936100715065214,0.0130916459656935,0.744680842096358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49031,0.00973260362866762,0.00862788876624061,-0.00717805835316397,0.0266432656104992,0.259316273602228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46155,-0.00946453534517988,0.00941744551875794,-0.0279227285619454,0.00899365787158569,0.314910569109482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46011,-0.000192658854055211,0.0384383420755258,-0.0755318093220859,0.0751464916139754,0.996000954619551
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46003,-0.0336976330801078,0.0374506070531929,-0.107100822904366,0.0397055567441502,0.368245158422468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46059,-0.0166243728609695,0.0122861926249122,-0.0407053104057974,0.00745656468385838,0.176043139465166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46021,-0.00107662374638937,0.022004076782923,-0.0442046142409184,0.0420513667481397,0.96097693591197
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46053,0.011942253424879,0.0156560820003441,-0.0187436672957954,0.0426281741455534,0.445600835802422
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46025,-0.00741848782971853,0.0180521093515687,-0.0428006221587932,0.0279636464993561,0.681115328422713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46029,-0.00150495415710399,0.0177021139240118,-0.0362010974481672,0.0331911891339592,0.932250040500612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46035,0.00492796993434569,0.0138455340957937,-0.02220927689341,0.0320652167621014,0.721901135961905
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46053,-0.00177729753288735,0.0176416921239257,-0.0363550140957818,0.0328004190300071,0.919754708717072
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46219,-0.00761195414017351,0.00716307412551838,-0.0216515794261895,0.0064276711458425,0.287948084817148
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46119,-0.00201957974309074,0.00996274194001914,-0.0215465539455283,0.0175073944593468,0.839361524516946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20127.Neuroticism score,47254,-0.0220515224327325,0.0351975117301525,-0.0910386454238314,0.0469356005583664,0.530989466860706
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35991,0.0106072886983365,0.0589625241832008,-0.104959258700737,0.12617383609741,0.857236938400733
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20161.Pack years of smoking,36678,-0.00358591368715919,0.00441433003348718,-0.0122380005527941,0.00506617317847568,0.416623513426053
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36678,-0.00415026105974785,0.00435336368608325,-0.012682853884471,0.00438233176497532,0.34044340996789
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20191.Fluid intelligence score,34127,-0.020041956893892,0.0644569466886611,-0.146377572403668,0.106293658615884,0.755861360702346
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34128,-0.0499884778335615,0.0673275188542416,-0.181950414787875,0.0819734591207519,0.45783590200675
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20240.Maximum digits remembered correctly,33605,-0.0438850752043172,0.0690447602426122,-0.179212805279837,0.0914426548712026,0.525064145187037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20255.Spirometry QC measure,45127,0.0316867982834376,0.0408995550670254,-0.0484763296479323,0.111849926214807,0.438500389468826
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20261.avMSE,33692,0.014833096140936,0.00512790857931965,0.00478239532546947,0.0248837969564025,0.00383661662012217
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20262.Myopia diagnosis,33692,-0.221198354171157,0.097853754897001,-0.412991713769279,-0.0294049945730351,0.0238323299455468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20280.Glucose-lactate,41816,-0.0002696697983919,0.00334958334947259,-0.00683485316335818,0.00629551356657438,0.935834086700098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20281.Spectrometer-corrected alanine,41840,0.00330579664347258,0.0035482417212355,-0.00364875713014901,0.0102603504170942,0.351523168083851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35751,0.0132815557169326,0.0200713144485641,-0.0260582206022531,0.0526213320361182,0.508173107078023
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35751,-0.0177741829192801,0.0442739533393123,-0.104551131464332,0.0690027656257719,0.688094116756123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35751,-0.105405608117479,0.0531158222209949,-0.209512619670629,-0.001298596564329,0.0472440349293262
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35751,0.0102883268484805,0.0194553306183806,-0.0278441211635454,0.0484207748605064,0.59694820005885
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35751,-0.0170973677038963,0.0275490134351737,-0.0710934340368367,0.0368986986290441,0.53487186875643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35755,0.0277885200443992,0.0370590443717464,-0.0448472069242237,0.100424247013022,0.453373027093938
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35755,-0.00685247374388689,0.0235661822967343,-0.0530421910454861,0.0393372435577123,0.771231279867951
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35755,-0.0285118694811363,0.0267947596602254,-0.081029598415178,0.0240058594529054,0.287326651285599
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35755,-0.00303069243940256,0.0387795545058577,-0.0790386192708837,0.0729772343920785,0.937709478799324
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35755,0.0179231772045209,0.0432912172272185,-0.0669276085608274,0.102773962969869,0.678876141948563
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35755,0.00202586882259039,0.0282758339781114,-0.053394765774508,0.0574465034196888,0.942885115403407
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35755,-0.0011715181512435,0.0418135396262706,-0.0831260558187338,0.0807830195162468,0.97764883569468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35755,0.00244813890948541,0.034165483150855,-0.0645162080661904,0.0694124858851613,0.94287821035358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35757,-0.0327365939065465,0.0576989839164504,-0.145826602382789,0.0803534145696962,0.570481548181764
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35757,-0.0137254442990767,0.0255422992036795,-0.0637883507382886,0.0363374621401352,0.591034743704203
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35757,-0.00306959952595112,0.0337699762338462,-0.0692587529442898,0.0631195538923875,0.927576742506231
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35757,-0.0540866493075108,0.0711627503870573,-0.193565640066143,0.0853923414511214,0.447254765648807
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20600.Liking for adding salt to foods,36437,-0.0836375324340261,0.0541653045324008,-0.189801529317532,0.0225264644494794,0.122600570831653
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20601.Liking for aniseed,36437,-0.0543205611692427,0.0557207671447506,-0.163533264772954,0.0548921424344684,0.329654366079695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20602.Liking for apple juice,36437,-0.0250754870909528,0.0561358807356491,-0.135101813332825,0.0849508391509194,0.655109323772641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20603.Liking for apples,36437,0.0895811570083608,0.0546063433056123,-0.0174472758706394,0.196609589887361,0.100943514886027
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20604.Liking for asparagus,36437,0.0620941183125339,0.0532877296891121,-0.0423498318781259,0.166538068503194,0.243948827503557
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20605.Liking for aubergine,36437,0.0107207613117972,0.0516057791451609,-0.090426565812718,0.111868088436312,0.83543471315741
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20606.Liking for avocados,36437,0.00813315355679918,0.0526976783256098,-0.0951542959613959,0.111420603074994,0.877348722214517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20607.Liking for bacon,36437,-0.0494458769251976,0.0521664852968963,-0.151692188107114,0.0528004342567192,0.343236312376749
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20608.Liking for baked or steamed fish,36437,0.0360304492394632,0.0526416898864307,-0.0671472629379411,0.139208161416867,0.493713178387276
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20609.Liking for bananas,36437,0.0688343626988776,0.0529273661322346,-0.0349032749203023,0.172572000318058,0.193452908837036
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36437,-0.0115702903665095,0.0515759292049711,-0.112659111608253,0.0895185308752339,0.822502434228301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20611.Liking for beef steak,36437,0.011212192395387,0.0535899504693889,-0.0938241105246153,0.116248495315389,0.834280444589583
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20612.Liking for beetroot,36437,-0.000703039116937221,0.0528916993423934,-0.104370769828028,0.102964691594154,0.989395129468488
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20613.Liking for bell pepper,36437,0.00534160263891131,0.0534392125008025,-0.0993992538626616,0.110082459140484,0.920381330992992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20614.Liking for bicycling,36437,-0.0648123460612174,0.0562174023176187,-0.17499845460375,0.0453737624813152,0.248991724963271
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20615.Liking for biscuits,36437,0.0707107604176784,0.0533043500443371,-0.0337657656692223,0.175187286504579,0.184697059557778
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20616.Liking for bitter foods,36437,-0.0765505297137161,0.0512217645967009,-0.17694518832325,0.0238441288958177,0.135087316118978
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20617.Liking for bitter or ale,36437,-0.0440620974007881,0.0532555470861871,-0.148442969689715,0.0603187748881386,0.408052009990671
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20618.Liking for black olives,36437,0.048857337599169,0.0510609578959706,-0.0512221398769334,0.148936815075271,0.33867588104864
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20619.Liking for black pepper,36437,-0.0424267097260838,0.0521583910237801,-0.144657156132693,0.0598037366805252,0.416001692255781
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20620.Liking for blue cheese,36437,0.000702123003832348,0.0537868152636275,-0.104720034912877,0.106124280920542,0.989585192962232
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20621.Liking for bolognese sauce,36437,0.0518645108855402,0.0534296205740276,-0.0528575454395538,0.156586567210634,0.331724157806117
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20622.Liking for broad beans,36437,0.0352172919136341,0.0528025046468592,-0.06827561719421,0.138710201021478,0.50481572819342
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20623.Liking for broccoli,36437,0.050915284694268,0.0531385200531347,-0.0532362146098761,0.155066783998412,0.338010913083427
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20624.Liking for brown rice,36437,0.0197878263290416,0.052476728483795,-0.0830665614991967,0.12264221415728,0.706125769348436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20625.Liking for brussel sprouts,36437,-0.027168583566249,0.0519465310461652,-0.128983784416733,0.0746466172842348,0.600981717181786
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20626.Liking for burgers (meat),36437,-0.0642638450151964,0.0542468139735429,-0.170587600403341,0.0420599103729477,0.236189222899532
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20627.Liking for burn of spicy foods,36437,-0.113350113852207,0.0544038266203053,-0.219981614028005,-0.00671861367640875,0.0372384683606327
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20628.Liking for butter on bread,36437,-0.0449448130356168,0.0542883684884233,-0.151350015272926,0.0614603892016929,0.407757873787344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20629.Liking for butternut squash,36437,0.0256727207637317,0.051507685029239,-0.0752823418935768,0.12662778342104,0.618198484087876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20630.Liking for cabbage,36437,0.0531219313209366,0.052605301996733,-0.0499844605926602,0.156228323234533,0.312612335993758
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20631.Liking for cake,36437,0.0047839551702974,0.0521860238237611,-0.0975006515242744,0.107068561864869,0.926961629656175
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20632.Liking for cake icing,36437,0.0107792765272064,0.0524147681765201,-0.0919536690987729,0.113512222153186,0.837066990958597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20633.Liking for capers,36437,0.0678542856300098,0.0519256929618035,-0.033920072575125,0.169628643835145,0.191333491358729
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20634.Liking for cauliflower,36437,0.0297275424101626,0.0539890199313905,-0.0760909366553628,0.135546021475688,0.581908533344887
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20635.Liking for cereal or granola bar,36437,0.0570749111070186,0.0526284138065482,-0.0460767799538159,0.160226602167853,0.278181648863086
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20636.Liking for cheesecake,36437,0.017498240518527,0.0531929891195471,-0.0867600181557854,0.121756499192839,0.742196501142768
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20637.Liking for cherries,36437,0.0564644510032553,0.0516843503832193,-0.0448368757478546,0.157765777754365,0.274652975903127
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20638.Liking for chicken,36437,0.0121565610962301,0.0550689532654641,-0.0957785873040796,0.12009170949654,0.825291586627611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20639.Liking for chilli pepper,36437,-0.0894606290011234,0.0523124299555713,-0.191992991714043,0.0130717337117964,0.0872829717639753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20640.Liking for chips or french fries,36437,-0.0108832600686488,0.0535243257813605,-0.115790938600115,0.0940244184628178,0.83888007330117
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20641.Liking for cigarette smoking,36437,0.0529629186369353,0.0854600416514153,-0.114538762999839,0.220464600273709,0.535447689128358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20642.Liking for cod,36437,0.0135211686572116,0.0545563854546266,-0.0934093468338565,0.12045168414828,0.80426592359425
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20643.Liking for coffee with sugar,36437,-0.0746137088379662,0.0573950093610441,-0.187107927185613,0.0378805095096802,0.193638071248593
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20644.Liking for coffee without sugar,36437,0.0495138584147884,0.0543716652282262,-0.057054605432535,0.156082322262112,0.362504934115928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20645.Liking for coriander,36437,-0.00450567149146646,0.0522088793552339,-0.106835075027725,0.0978237320447919,0.931229457431912
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20646.Liking for corn flakes,36437,0.0539146280107599,0.0546524541309433,-0.0532041820858888,0.161033438107409,0.323918466577853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20647.Liking for cream,36437,-0.040717594865329,0.0559612761451398,-0.150401696109803,0.0689665063791451,0.466878377632922
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20648.Liking for croissant,36437,-0.00781900034308742,0.0525292479172144,-0.110776326260828,0.0951383255746528,0.881675502673723
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20649.Liking for cucumber,36437,0.0566402010851885,0.0518366760741295,-0.0449596840201053,0.158240086190482,0.274573864644349
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20650.Liking for curry,36437,-0.0890865662884668,0.0531957953460654,-0.193350325166755,0.0151771925898215,0.094034646968067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20651.Liking for dairy products,36437,0.00968747681507307,0.0556105902874138,-0.099309280148258,0.118684233778404,0.861711207707541
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20652.Liking for dark chocolate,36437,-0.0216794588844527,0.0514939852168473,-0.122607669909473,0.0792487521405679,0.673759675899806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20653.Liking for diet fizzy drinks,36437,0.0133697520118739,0.0536884941704525,-0.0918596965622131,0.118599200585961,0.80334834025277
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20654.Liking for dried fruit,36437,0.0359205761469132,0.0512039346827884,-0.0644391358313521,0.136280288125178,0.482999511049439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20655.Liking for eggs,36437,0.0823674564335039,0.0543101414286454,-0.0240804207666412,0.188815333633649,0.129404847488181
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20656.Liking for exercising alone,36437,0.0158756644148427,0.0524383963828613,-0.0869035924955655,0.118654921325251,0.762089307953593
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20657.Liking for exercising with others,36437,0.0130791947356885,0.0512259591514148,-0.0873236852010846,0.113482074672462,0.798479905192241
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20658.Liking for extra virgin olive oil,36437,-0.011352870384604,0.0519289547691267,-0.113133621732092,0.0904278809628842,0.826949336396249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20659.Liking for fatty foods,36437,-0.062860120682715,0.0546788773715516,-0.170030720330956,0.0443104789655261,0.250334109271804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20660.Liking for fresh tomatoes,36437,0.0483809220361289,0.0555355738114884,-0.0604688026343883,0.157230646706646,0.38368809090042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20661.Liking for fried chicken,36437,-0.105716911439177,0.0531979210228166,-0.209984836643898,-0.0014489862344569,0.0469308606850382
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20662.Liking for fried or battered fish,36437,0.0435268060170882,0.0525700187277844,-0.0595104306893693,0.146564042723546,0.407708340031847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20663.Liking for fruit,36437,0.0953836582071894,0.0559964282672107,-0.0143693411965436,0.205136657610922,0.0885351275307623
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20664.Liking for garlic,36437,0.029897507260585,0.0528411878221334,-0.0736712208707964,0.133466235391966,0.571546437573799
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20665.Liking for gherkins,36437,-0.012379011891215,0.0517013727575412,-0.113713702495996,0.0889556787135657,0.810776155654259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20666.Liking for globe artichoke,36437,0.0150980655800858,0.0532845528560496,-0.0893396580177713,0.119535789177943,0.776917663294687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20667.Liking for goat's cheese,36437,-0.0435445566558194,0.0542128345750344,-0.149801712422887,0.0627125991112481,0.421874920463958
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20668.Liking for going to a cafe,36437,0.00791065332959158,0.0524552289487635,-0.0949015954099849,0.110722902069168,0.880131284240594
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20669.Liking for going to the gym,36437,-0.0574867514156415,0.0518103386387342,-0.159035015147561,0.0440615123162776,0.267222160511604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20670.Liking for going to the pub,36437,-0.0263272090873284,0.0513830045535068,-0.127037898012202,0.074383479837545,0.608405189810744
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20671.Liking for grapefruit,36437,-0.0226160240813837,0.052312970348988,-0.1251494459654,0.0799173978026328,0.665519640031907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20672.Liking for green olives,36437,0.085778778348144,0.0507607135501358,-0.0137122202101221,0.18526977690641,0.0910935082087172
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20673.Liking for haddock,36437,0.030380168893624,0.0535497175369932,-0.0745772774788826,0.135337615266131,0.570508707041336
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20674.Liking for ham,36437,-0.0221450554979995,0.0517701086470831,-0.123614468446282,0.0793243574502833,0.668839403277794
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20675.Liking for hard cheese,36437,0.0304601188621024,0.0535304553444843,-0.0744595736130867,0.135379811337292,0.569356114157999
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20676.Liking for herring,36437,-0.00977162641250125,0.0520121827562793,-0.111715504614809,0.0921722517898062,0.850981958387166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20677.Liking for honey,36437,-0.0367251489125459,0.0535356771601486,-0.141655076146437,0.0682047783213455,0.492737260116458
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20678.Liking for horseradish or wasabi,36437,-0.0586148798786732,0.054951639491052,-0.166320093281135,0.0490903335237887,0.286156942656561
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20679.Liking for ice cream,36437,-0.0581371210542678,0.0531584344112754,-0.162327652500368,0.046053410391832,0.274138868430907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20680.Liking for jam,36437,-0.018923482230678,0.0552228987637472,-0.127160363807623,0.0893133993462666,0.731852508280611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20681.Liking for kiwi fruit,36437,0.0466342934709237,0.0524745719278552,-0.0562158675076724,0.14948445444952,0.374190189567514
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20682.Liking for lager,36437,0.00903075018325078,0.0531908278879219,-0.0952232724770761,0.113284772843578,0.865187374572942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20683.Liking for lamb,36437,0.0358713729536543,0.0516194076641864,-0.065302666068151,0.13704541197546,0.48712589155258
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20684.Liking for lemons,36437,0.0414793095141995,0.0522460440495663,-0.0609229368229505,0.14388155585135,0.427264620103022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20685.Liking for lentils or beans,36437,-0.012063375066308,0.0523943531820757,-0.114756307303176,0.0906295571705604,0.817909826431955
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20686.Liking for liver,36437,-0.0452554770790537,0.0533918884894674,-0.14990357851841,0.0593926243603024,0.396681342258802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20687.Liking for mackerel,36437,0.00098079863312003,0.0530690015734681,-0.103034444450878,0.104996041717118,0.985255148589726
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20688.Liking for marzipan,36437,0.0846660122068511,0.0511420022664396,-0.0155723122353705,0.184904336649073,0.0978615065473855
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20689.Liking for mayonnaise,36437,-0.0106257759896506,0.0537171033724279,-0.115911298599609,0.0946597466203081,0.843198919703802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20690.Liking for melon,36437,0.0452685609712584,0.0538291474785307,-0.0602365680866618,0.150773690029178,0.400391855979249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20691.Liking for milk chocolate,36437,-0.0489485730477508,0.0539989031265601,-0.154786423175809,0.0568892770803069,0.364713202241673
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20692.Liking for mushrooms,36437,0.0412605201113817,0.0523008653129013,-0.0612491759019049,0.143770216124668,0.430190240664945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20694.Liking for orange juice,36437,-0.000400099290662059,0.0554634434788908,-0.109108448509288,0.108308249927964,0.994244495783941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20695.Liking for oranges,36437,-0.0738666183337207,0.0529834617592611,-0.177714203381872,0.0299809667144309,0.163313448129614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20696.Liking for pasta,36437,0.0838176528959255,0.0526682757592217,-0.0194121675921489,0.187047473384,0.111554160462218
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20697.Liking for pears,36437,0.043870881609778,0.0536424123949647,-0.0612682466843529,0.149010009903909,0.413473754806689
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20698.Liking for pizza,36437,0.0501638163413839,0.0527195432573546,-0.053166488443031,0.153494121125799,0.341368726691046
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20699.Liking for plain yogurt,36437,0.0259950434844618,0.0504307955641743,-0.0728493158213199,0.124839402790243,0.606246370021966
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20700.Liking for plums,36437,0.0291340001651749,0.0527502514945903,-0.074256492764222,0.132524493094572,0.580758127815889
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20701.Liking for pollock,36437,0.0185732028039216,0.05173346165781,-0.082824382045386,0.119970787653229,0.719591901301051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20702.Liking for pork chop,36437,0.00815965384733683,0.053257256289822,-0.0962245684807144,0.112543876175388,0.878234997985037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20703.Liking for porridge,36437,-0.0266315755989499,0.053919251801938,-0.132313309130748,0.0790501579328485,0.621379435451042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20704.Liking for potato crisps,36437,-0.0254672254446227,0.0531208837842734,-0.129584157661798,0.0786497067725532,0.631653109287301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20705.Liking for potatoes,36437,0.00917336292181645,0.0523344466440197,-0.0934021525004621,0.111748878344095,0.860861439947512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20706.Liking for prawns,36437,-0.0445751407138836,0.0524417547649487,-0.147360980053183,0.0582106986254159,0.395354801460144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20707.Liking for raw carrots,36437,0.0775103030655214,0.0507637759171877,-0.0219866977321666,0.177007303863209,0.126830721639127
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20708.Liking for red meat,36437,-0.0296917823566652,0.0526524460339577,-0.132890576583222,0.0735070118698919,0.572824539197971
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20709.Liking for red wine,36437,0.107618355471358,0.052608824178484,0.0045050600815288,0.210731650861186,0.0408258285067287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36437,0.0112641669847427,0.0534051849659685,-0.0934099955485555,0.115938329518041,0.832955985747737
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20711.Liking for roast chicken,36437,0.0312612958584496,0.0558003382742994,-0.0781073671591773,0.140629958876076,0.575335269994079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20712.Liking for salad dressing,36437,-0.0291089715776966,0.0540486551991846,-0.135044335768098,0.0768263926127053,0.590199067924845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20713.Liking for salad leaves,36437,0.113652679526205,0.054963076244846,0.00592505008630724,0.221380308966104,0.0386915596851666
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20714.Liking for salami,36437,-0.0564105027495375,0.0503950795897591,-0.155184858745465,0.0423638532463904,0.263018678488982
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20715.Liking for salmon,36437,0.0364694267729927,0.0515818068112834,-0.0646309145771227,0.137569768123108,0.479574399209826
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20716.Liking for salty foods,36437,-0.0745001195703576,0.052048824972205,-0.176515816515879,0.0275155773751643,0.152369664966362
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20717.Liking for salty pretzels,36437,0.000636142023132182,0.0519397116913542,-0.101165692891922,0.102437976938186,0.990228305437101
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20718.Liking for sardines,36437,0.0349884530461757,0.0535444586577228,-0.069958685922961,0.139935592015312,0.513487493982645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20719.Liking for sausages (meat),36437,-0.0265412309046302,0.0522343908020862,-0.128920636876719,0.0758381750674587,0.611384954096047
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20720.Liking for savoury biscuits,36437,0.0337225869484496,0.0530985701743164,-0.0703506105932107,0.13779578449011,0.525385628037782
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36437,0.0386069065982838,0.0524794180334033,-0.0642527527471866,0.141466565943754,0.461960863342476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20722.Liking for skimmed milk,36437,-0.00747901558101402,0.0545022298989442,-0.114303386182945,0.0993453550209167,0.890857247217705
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20723.Liking for smoked fish,36437,0.0605071757277491,0.0527719528441135,-0.0429258518467132,0.163940203302212,0.251590996571654
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20724.Liking for soft cheese,36437,0.0424802779612068,0.053474154235267,-0.0623290643399164,0.14728962026233,0.426982226196116
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20725.Liking for soy sauce,36437,-0.0871601617947909,0.0523563883334539,-0.189778682928361,0.0154583593387787,0.0960031801902106
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20726.Liking for soya milk,36437,-0.00323170372436167,0.0528359444724778,-0.106790154890418,0.100326747441695,0.951229467732545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20727.Liking for spicy foods,36437,-0.11139709915017,0.0530376176680366,-0.215350829779522,-0.00744336852081828,0.0357307392806001
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20728.Liking for spinach,36437,0.0738327942842835,0.0537203116462259,-0.0314590165423193,0.179124605110886,0.169359202960049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20729.Liking for spirits,36437,0.0459664974517141,0.0529023398183388,-0.05772208859223,0.149655083495658,0.38493204199533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20730.Liking for strawberries,36437,0.0313700313366188,0.0555010218402483,-0.0774119714702678,0.140152034143506,0.571943472522624
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36437,-0.0480882570455573,0.0549173626431278,-0.155726287826088,0.0595497737349732,0.381248504731298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20732.Liking for sweet foods,36437,-0.063197630211891,0.0521541713139695,-0.165419805987271,0.0390245455634892,0.225646040279614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20733.Liking for taking the stairs,36437,-0.0614494011268022,0.0542344523681591,-0.167748927768394,0.0448501255147897,0.257235275667087
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20734.Liking for tea with sugar,36437,-0.0670671550396784,0.0614496258924676,-0.187508421788915,0.0533741117095581,0.275123107198978
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20735.Liking for tea without sugar,36437,0.0438303118583736,0.0562925350459875,-0.0665030568317619,0.154163680548509,0.436229031614802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20736.Liking for tomato ketchup,36437,-0.0315105887883136,0.0536222464979298,-0.136610191924256,0.0735890143476288,0.55679075802302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20737.Liking for tinned tuna,36437,0.0642142127781247,0.0505880811607634,-0.0349384262969716,0.163366851853221,0.204352363041508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20738.Liking for turnip (white),36437,0.013791640500134,0.0532403711697438,-0.0905594869925638,0.118142767992832,0.795607497442853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20739.Liking for vegetables,36437,0.0592929542790811,0.0555732619663106,-0.0496306391748877,0.16821654773305,0.286034937060384
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20740.Liking for vinegar,36437,-0.0165738555852288,0.0522259036273617,-0.118936626694858,0.0857889155244002,0.750987013201803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20741.Liking for watching television,36437,0.0176692544851975,0.0508198585411677,-0.0819376682554912,0.117276177225886,0.728086820794547
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20742.Liking for whisky,36437,0.0791777604851072,0.0537608431134253,-0.0261934920172064,0.184549012987421,0.14085124423564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20743.Liking for white bread,36437,0.0538844324572844,0.052207702579806,-0.0484426645991354,0.156211529513704,0.302049420399728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20744.Liking for white rice,36437,-0.00277097916287969,0.051938013554688,-0.104569485730068,0.0990275274043088,0.957453082640369
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20745.Liking for white wine,36437,0.100685102854777,0.051402903462479,-6.45879316814174e-05,0.201434793641236,0.0501782866223092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36437,0.05890780806457,0.0546297830404633,-0.0481665666947381,0.165982182823878,0.280928933556785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20747.Liking for whole milk,36437,-0.0182523896856138,0.0542605079751644,-0.124602985316936,0.0880982059457084,0.736590010762214
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20748.Liking for wholemeal bread,36437,0.0266442616463885,0.0524959375199719,-0.0762477758927564,0.129536299185533,0.611783949411739
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20749.Liking for working up a sweat,36437,0.00164839097577281,0.0531903642837685,-0.102604723020413,0.105901504971959,0.975277981088318
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21001.Body mass index (BMI),51613,-0.0241854091013743,0.0128644965816135,-0.0493998224013368,0.00102900419858826,0.0601190514745291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21002.Weight,51645,-0.00861558917228784,0.00622553467625929,-0.0208176371377561,0.00358645879318038,0.16639895089504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21021.Pulse wave Arterial Stiffness index,36322,-0.00206852088294082,0.00470260466249485,-0.0112856260214307,0.00714858425554909,0.660045705428757
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36201,0.039807503492289,0.056229329489056,-0.0704019823062609,0.150016989290839,0.478998585316547
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36203,-0.0956077069502743,0.0562145520996214,-0.205788229065532,0.0145728151649837,0.0890281533263518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36204,0.0179372967461474,0.0554511099585608,-0.0907468787726319,0.126621472264927,0.74634103734034
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21040.Satisfaction with bowel habits,36177,-0.0121037753231783,0.050853256914967,-0.111776158876514,0.087568608230157,0.811876858775099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36175,0.0364790915111393,0.0554691331558267,-0.072240409474281,0.14519859249656,0.510785195541674
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21042.Greatest number of times bowels opened per day,36172,-0.0378544140924204,0.0564820531556314,-0.148559238277458,0.0728504100926172,0.502749141846138
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21043.Least number of times bowels opened per week,36139,-0.103705608616391,0.0549000219439864,-0.211309651626604,0.00389843439382223,0.0589314802893662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21044.Average number of times bowels opened per day,36148,0.00152821859562737,0.0629928162561374,-0.121937701266402,0.124994138457657,0.980645698083538
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36210,-0.00143419381811197,0.057221831008681,-0.113588982595127,0.110720594958903,0.980004769540739
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36206,-0.0228667109457653,0.058497486310755,-0.137521784114845,0.0917883622233145,0.69588155368424
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36208,0.0486510886995482,0.0693063667826229,-0.0871893901943927,0.184491567593489,0.482718463634714
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36208,-0.0488976027714165,0.0795876283756593,-0.204889354387709,0.107094148844876,0.538978010835871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36208,0.0940085428570658,0.0736657080165636,-0.0503762448553988,0.23839333056953,0.201941223088146
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36207,0.122500875348111,0.191023375189485,-0.251904940023279,0.496906690719501,0.521355324844449
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36210,-0.0446589341991303,0.069299616084263,-0.180486181724286,0.0911683133260251,0.519314353946445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36208,0.0110333004534023,0.0641843608114114,-0.114768046736964,0.136834647643769,0.863520611061678
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36068,-0.0254712761818013,0.0639501034296521,-0.150813478903919,0.0998709265403167,0.690421026113536
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36204,-0.0276886960211623,0.0578170036756644,-0.141010023225465,0.08563263118314,0.63202190715847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36209,-0.0465452534447245,0.0953617304443427,-0.233454245115636,0.140363738226187,0.625499072398731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36210,-0.0243419863853518,0.055899931396499,-0.13390585192249,0.0852218791517863,0.663243485865725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36209,0.0450441433040463,0.0564380084879067,-0.0655743533322509,0.155662639940343,0.424827412513518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X21100.Water hardness (USGS classification),51485,-0.0373812138678978,0.0342159884995617,-0.104444551327039,0.0296821235912431,0.274621728103981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2139.Age first had sexual intercourse,48720,-0.00225436736525054,0.00256224281754051,-0.00727636328762993,0.00276762855712885,0.37895572983654
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2149.Lifetime number of sexual partners,47071,0.0757374035102187,0.0386713423940663,-5.84275821511604e-05,0.151533234602589,0.050187673675409
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22032.IPAQ activity group,47933,0.0583817157142694,0.0370482400001523,-0.0142328346860291,0.130996266114568,0.11508142633367
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22033.Summed days activity,48329,0.00474275071089709,0.0025292487563414,-0.000214576851532053,0.00970007827332624,0.0607852233113814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22034.Summed minutes activity,47933,0.00313935272202491,0.00256296376815221,-0.00188405626355342,0.00816276170760324,0.220630999540009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22037.MET minutes per week for walking,47228,0.00402468078676022,0.00260713306661679,-0.0010853000238087,0.00913466159732913,0.122673414130436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22038.MET minutes per week for moderate activity,47933,0.00110153963442727,0.0026059847417929,-0.00400619045948681,0.00620926972834134,0.672521689246209
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22039.MET minutes per week for vigorous activity,47933,0.0950315054384184,0.0365582371526595,0.0233773606192058,0.166685650257631,0.00934427732067412
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22040.Summed MET minutes per week for all activity,47228,0.00597171512459822,0.00258692283893439,0.000901346360286822,0.0110420838889096,0.0209864532542319
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X2217.Age started wearing glasses or contact lenses,48007,-0.00341852536457532,0.00260587897436739,-0.0085260481543354,0.00168899742518476,0.189585875499663
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X22501.Year ended full time education,34050,0.0118373484958179,0.013019949849831,-0.0136817532098509,0.0373564502014868,0.363300572318067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X22506.Tobacco smoking,34013,0.192863002423917,0.111592725932085,-0.0258587404029699,0.411584745250804,0.0839958472237385
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50289,-0.009335660208644,0.10532036871399,-0.215763582888065,0.197092262470777,0.929368362881615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23098.Weight,51213,-0.0074101052936063,0.0062757119494278,-0.0197105007144848,0.00489029012727219,0.237710772950017
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23099.Body fat percentage,51184,-0.000366860112395724,0.00559077125550422,-0.011324771773184,0.0105910515483925,0.94768184334313
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23100.Whole body fat mass,51143,-0.00249323387099858,0.00558290406279702,-0.0134357258340807,0.00844925809208358,0.655179967196412
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23101.Whole body fat-free mass,51207,-0.00597578723124263,0.00541864244704439,-0.0165963264274496,0.00464475196496436,0.270117083079821
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23102.Whole body water mass,51213,-0.00637540250431136,0.00540355117758481,-0.0169663628123776,0.00421555780375487,0.238070623694414
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23104.Body mass index (BMI),51213,-0.0215053824459384,0.0127110639556879,-0.0464190677990868,0.00340830290720992,0.0906858212179439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23105.Basal metabolic rate,51213,-0.00609396624503391,0.00563024003321434,-0.017129236710134,0.0049413042200662,0.279102586664707
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23106.Impedance of whole body,51213,0.00220972390996519,0.0044307852547112,-0.00647461518926877,0.0108940630091991,0.617981076529922
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23107.Impedance of leg (right),51213,0.00525624649695374,0.00358224155432622,-0.00176494694952565,0.0122774399434331,0.142306590049769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23108.Impedance of leg (left),51213,0.0028003431900163,0.00357521926326919,-0.00420708656599131,0.0098077729460239,0.433479866958612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23109.Impedance of arm (right),51213,0.00023703731541406,0.00438322208375606,-0.00835407796874782,0.00882815259957594,0.956873237563804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23110.Impedance of arm (left),51213,0.00151618128121489,0.00438256943675597,-0.00707365481482682,0.0101060173772566,0.729378127894681
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23111.Leg fat percentage (right),51213,0.00355877586710088,0.00569151525828298,-0.00759659403913375,0.0147141457733355,0.531795319410827
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23112.Leg fat mass (right),51213,0.0015638309980965,0.00613242188137674,-0.0104557158894019,0.0135833778855949,0.798717430979498
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23113.Leg fat-free mass (right),51212,-0.00810000499449543,0.00595599608369647,-0.0197737573185405,0.00357374732954965,0.17385143544041
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23114.Leg predicted mass (right),51212,-0.00776173597417613,0.00599971013808206,-0.019521167844817,0.00399769589646472,0.195787407346277
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23115.Leg fat percentage (left),51212,0.00100123563480205,0.00596398669994766,-0.0106881782970954,0.0126906495666995,0.866678981722865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23116.Leg fat mass (left),51212,-0.00134319831426746,0.00649537346205446,-0.0140741302998942,0.0113877336713593,0.836173319039954
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23117.Leg fat-free mass (left),51211,-0.00659051453227779,0.00648672930522769,-0.0193045039705241,0.00612347490596847,0.309640436967036
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23118.Leg predicted mass (left),51211,-0.00678439435957253,0.00653822960385004,-0.0195993243831186,0.00603053566397354,0.299444097835736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23119.Arm fat percentage (right),51211,-0.00484899416782926,0.00627857981414437,-0.0171550106035522,0.00745702226789369,0.439940407027218
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23120.Arm fat mass (right),51210,-0.0123086694772576,0.00685422881827071,-0.0257429579610682,0.00112561900655298,0.0725432670616015
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23121.Arm fat-free mass (right),51209,-0.00670702425277821,0.00593833934260135,-0.0183461693642769,0.00493212085872044,0.258722384886354
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23122.Arm predicted mass (right),51209,-0.00751028702350769,0.00596483984025707,-0.0192013731104115,0.00418079906339616,0.208009806274738
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23123.Arm fat percentage (left),51207,-0.00278197234500767,0.0059172029128762,-0.014379690054245,0.00881574536422969,0.63825246198819
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23124.Arm fat mass (left),51207,-0.0102559045222598,0.00658967147314353,-0.0231716606096211,0.00265985156510152,0.119636385751455
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23125.Arm fat-free mass (left),51203,-0.00674013223632652,0.0054102779936203,-0.0173442771038223,0.00386401263116926,0.212850205512036
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23126.Arm predicted mass (left),51202,-0.00625533275003231,0.00543972304263099,-0.0169171899135891,0.00440652441352443,0.250182445059624
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23127.Trunk fat percentage,51200,-0.000584322402697564,0.00473542449404473,-0.00986575441102524,0.00869710960563011,0.901796300221022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23128.Trunk fat mass,51200,-0.00245337652585976,0.00499249164406022,-0.0122386601482178,0.00733190709649828,0.623138969522224
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23129.Trunk fat-free mass,51199,-0.00474686807878568,0.0046957174909363,-0.0139504743610208,0.00445673820344946,0.312078453744114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23130.Trunk predicted mass,51197,-0.00493032404086037,0.00469163260603458,-0.0141259239486882,0.0042652758669674,0.293326788844658
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23400.Total Cholesterol,41843,0.0136142501629748,0.00354516031605453,0.00666573594350788,0.0205627643824416,0.000123488917907258
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41843,0.0121508794973151,0.00346429798541675,0.00536085544589832,0.018940903548732,0.000453909082707643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41843,0.0119065494209795,0.00348592844758995,0.0050741296637032,0.0187389691782558,0.000638318682257521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23403.VLDL Cholesterol,41843,0.010410651810864,0.00359757749837084,0.00335939991405716,0.0174619037076709,0.00381237520115409
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23404.Clinical LDL Cholesterol,41843,0.0113156827659847,0.00345761089200498,0.00453876541765499,0.0180926001143145,0.00106802747297751
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23405.LDL Cholesterol,41843,0.0120250987192902,0.00344024402981028,0.00528222042086201,0.0187679770177183,0.000474864337525912
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23406.HDL Cholesterol,41843,0.00778952309546057,0.00392876167284831,8.91502166778775e-05,0.0154898959742433,0.04742250837343
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23407.Total Triglycerides,41843,0.00570528557492481,0.00366515308628657,-0.00147841447419686,0.0128889856240465,0.119582361307268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23408.Triglycerides in VLDL,41843,0.00525249160730804,0.00372016739270324,-0.00203903648239031,0.0125440196970064,0.158003911513573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23409.Triglycerides in LDL,41843,0.00621079204038825,0.00344979695337306,-0.000550809988222943,0.0129723940689994,0.0718304200943406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23410.Triglycerides in HDL,41843,0.00589938920216892,0.00358876849891721,-0.00113459705570882,0.0129333754600467,0.100231382273919
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41843,0.0132478016835576,0.00356409919091649,0.00626216726936127,0.0202334360977539,0.000202422756120371
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23412.Phospholipids in VLDL,41843,0.00844678094708896,0.00363988419787325,0.0013126079192574,0.0155809539749205,0.0203225797826979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23413.Phospholipids in LDL,41843,0.0113801844237196,0.00345262124431678,0.00461304678485869,0.0181473220625805,0.0009829498607814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23414.Phospholipids in HDL,41843,0.00696735865868129,0.00376309456606798,-0.000408306690811955,0.0143430240081745,0.0641203178373126
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23415.Total Esterified Cholesterol,41843,0.0134862681909746,0.00356416854549957,0.0065004978417954,0.0204720385401537,0.00015510305798281
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41843,0.0109498881818895,0.00357688761358846,0.00393918845925617,0.0179605879045229,0.00220827410424268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41843,0.0120878362060009,0.00343920742584903,0.00534698965133677,0.018828682760665,0.000441695218504911
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41843,0.00699910588520806,0.00393269082437746,-0.000708968130571762,0.0147071799009879,0.0751439979544879
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23419.Total Free Cholesterol,41843,0.0136536085086444,0.00350191202552306,0.00678986093861923,0.0205173560786696,9.71068811774679e-05
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23420.Free Cholesterol in VLDL,41843,0.0093166505879993,0.00362349610973594,0.00221459821291686,0.0164187029630817,0.0101461597689869
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23421.Free Cholesterol in LDL,41843,0.0113260890726631,0.00346015435443291,0.0045441865379746,0.0181079916073516,0.00106575774664634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23422.Free Cholesterol in HDL,41843,0.00994351378568906,0.0039050183841466,0.00228967775276173,0.0175973498186164,0.0108970582584363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41843,0.0124848076962464,0.00342492703692899,0.00577195070386556,0.0191976646886272,0.000268126508540655
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23424.Total Lipids in VLDL,41843,0.00752813946467804,0.00364446904271225,0.000384980140962035,0.0146712987883941,0.0388824519838034
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23425.Total Lipids in LDL,41843,0.0119165473936766,0.0034405996336217,0.00517297211177809,0.0186601226755751,0.000534864661088177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23426.Total Lipids in HDL,41843,0.00782884753120311,0.00382416308549229,0.000333487883638208,0.015324207178768,0.0406576064319673
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41843,0.0101864756195053,0.00362569485543976,0.00308011370284335,0.0172928375361672,0.0049687596204984
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23428.Concentration of VLDL Particles,41843,0.0103543135000143,0.00359127877563115,0.00331540709977722,0.0173932199002513,0.00394312572724408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23429.Concentration of LDL Particles,41843,0.0115618375257608,0.00345970176949765,0.00478082205754546,0.0183428529939762,0.000834494823203369
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23430.Concentration of HDL Particles,41843,0.00845996991407225,0.00362995940059422,0.00134524948890757,0.0155746903392369,0.019789594254188
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41843,-0.000116684453828543,0.00377913972232399,-0.00752379830958357,0.00729042940192648,0.975368951064967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23432.Average Diameter for LDL Particles,41843,0.000678471312919158,0.00358192553208525,-0.00634210272996793,0.00769904535580624,0.849770277457548
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23433.Average Diameter for HDL Particles,41843,0.00500490134946959,0.0039404502437497,-0.00271838112827982,0.012728183827219,0.204059080366311
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23434.Phosphoglycerides,41834,0.0119000525463865,0.00357498411873944,0.00489308367365723,0.0189070214191158,0.000874902292409542
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41834,0.000463663457739825,0.00387002174734756,-0.0071215791670614,0.00804890608254105,0.904636266426823
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23436.Total Cholines,41834,0.0130242149827095,0.00363444569211944,0.00590070142615536,0.0201477285392635,0.000340174838780118
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23437.Phosphatidylcholines,41834,0.0133290150636527,0.00364979780604723,0.00617541136380016,0.0204826187635053,0.000261222576006759
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23438.Sphingomyelins,41834,0.0135947303947066,0.0036664519676837,0.00640848453804657,0.0207809762513667,0.000209862770374982
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23439.Apolipoprotein B,41843,0.0114368456722656,0.00347236360044696,0.00463101301538955,0.0182426783291416,0.000991452559056456
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23440.Apolipoprotein A1,41843,0.00791780730404918,0.00374176831577037,0.000583941405139257,0.0152516732029591,0.0343582902807512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41843,0.00638509670276502,0.00355127460785327,-0.000575401528627384,0.0133455949341574,0.0722040169471857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23442.Total Fatty Acids,41834,0.00841539973913508,0.00334194775414438,0.0018651821410121,0.0149656173372581,0.0118102697900212
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23443.Degree of Unsaturation,41834,0.00273077109712507,0.00363836653743811,-0.00440042731625362,0.00986196951050376,0.452937677936439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23444.Omega-3 Fatty Acids,41834,0.00725222727398242,0.00352082886698817,0.00035140269468562,0.0141530518532792,0.0394365246877221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23445.Omega-6 Fatty Acids,41834,0.0104908214255861,0.00345649624589626,0.00371608878362941,0.0172655540675428,0.00240920769280462
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41834,0.0107776324510939,0.00347249031283754,0.00397155143793235,0.0175837134642555,0.00191507952931278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41834,0.00573224187144639,0.00340949959552065,-0.000950377335774085,0.0124148610786669,0.0927367841420551
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23448.Saturated Fatty Acids,41834,0.00772188722613955,0.00329786891423716,0.00125806415423471,0.0141857102980444,0.019222318146611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23449.Linoleic Acid,41834,0.0100040570674394,0.00345268938765942,0.00323678586762695,0.0167713282672519,0.00376805085370837
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23450.Docosahexaenoic Acid,41834,0.00731963734326496,0.00350064107399295,0.000458380838238783,0.0141808938482911,0.0365522909057935
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41834,0.00362124091954416,0.00353717978309325,-0.00331163145531861,0.0105541132944069,0.305964990582594
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41834,-0.00226954857315776,0.0034721393892439,-0.0090749417760758,0.00453584462976028,0.51335152661746
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41834,-0.000584857334485844,0.00355701572159791,-0.00755660814881774,0.00638689347984605,0.869400196435515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41834,-0.00124755827416268,0.0037393510570034,-0.00857668634588935,0.00608156979756398,0.738664349607615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41834,0.00222183285749823,0.00323096563238551,-0.00411085978197737,0.00855452549697383,0.491673696752806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41834,0.0014940216276183,0.00356040502721569,-0.00548437222572446,0.00847241548096105,0.674768969664494
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41834,0.00196628112775916,0.00346736939988753,-0.0048297628960204,0.00876232515153873,0.570668412317961
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41834,0.000314748300134736,0.00370277485086429,-0.00694269040755927,0.00757218700782874,0.932260006055782
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41834,-0.00357427204776722,0.00349060064358593,-0.0104158493091956,0.00326730521366119,0.305867930560279
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23460.Alanine,41840,0.00162415514076934,0.00348009802781625,-0.0051968369937505,0.00844514727528919,0.640723567636693
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23461.Glutamine,41805,0.00610633039824724,0.00343374136980967,-0.000623802686579723,0.0128364634830742,0.0753724308928089
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23462.Glycine,41829,0.000862399365127749,0.00414279566035594,-0.0072574801291699,0.0089822788594254,0.835100644218775
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23463.Histidine,41826,0.00651889131077689,0.00344972103640498,-0.000242561920576876,0.0132803445421307,0.0588217484704117
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41833,0.00573807655974978,0.00386346812366048,-0.00183432096262477,0.0133104740821243,0.13751099159806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23465.Isoleucine,41841,0.00530002235256405,0.00372842751777309,-0.0020076955822712,0.0126077402873993,0.155190124843316
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23466.Leucine,41841,0.00634603150798085,0.00382649683969882,-0.00115390229782883,0.0138459653137905,0.0972515263998621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23467.Valine,41833,0.0050445660352914,0.00383938064538242,-0.00248062002965815,0.0125697521002409,0.188902301594837
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23468.Phenylalanine,41835,0.00420857652955706,0.00354471529491154,-0.00273906544846956,0.0111562185075837,0.235137729259598
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23469.Tyrosine,41829,0.00361490760952669,0.00368185960434649,-0.00360153721499244,0.0108313524340458,0.326208601134424
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23470.Glucose,41821,0.000847313960034991,0.00334428088516464,-0.00570747657488771,0.00740210449495769,0.799992367320436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23471.Lactate,41823,-0.00218169975219813,0.00353608243368599,-0.00911242132222269,0.00474902181782642,0.537257120622821
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23472.Pyruvate,41803,0.00339563453542514,0.00339842181154997,-0.0032652722152128,0.0100565412860631,0.317725895388332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23473.Citrate,41841,-0.000176872345714047,0.00350403315451576,-0.00704477732856494,0.00669103263713684,0.959743206089508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23474.3-Hydroxybutyrate,41571,0.000199872646192146,0.00388251709405709,-0.00740986085815974,0.00780960615054403,0.958943694392822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23475.Acetate,41831,0.00646032231789811,0.0033512477651789,-0.000108123301852539,0.0130287679376488,0.0539093000914261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23476.Acetoacetate,41842,0.00224859679141379,0.00351807144498691,-0.00464682324076056,0.00914401682358814,0.522732449259477
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23477.Acetone,41842,-0.00139286830306368,0.00350113743052602,-0.00825509766689468,0.00546936106076731,0.690759641059034
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23478.Creatinine,41597,0.0012414522252807,0.00422818185505541,-0.00704578421062789,0.0095286886611893,0.769057774806322
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23479.Albumin,41841,0.00828304005851606,0.00348531448723462,0.00145182366353621,0.0151142564534959,0.0174893086433687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23480.Glycoprotein Acetyls,41843,0.00171269538860229,0.00362321745400379,-0.00538881082124514,0.00881420159844971,0.636434918520092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41843,0.00267772193916899,0.00368679780853727,-0.00454840176556406,0.00990384564390203,0.467667600833695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41843,0.00184961180483138,0.00366533041439498,-0.00533443580738279,0.00903365941704554,0.61383170826439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41843,0.0017714410761327,0.00378778608360488,-0.00565261964773286,0.00919550179999826,0.64002694174403
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41843,0.00254658043178636,0.00372523029465978,-0.00475487094574682,0.00984803180931953,0.494237540275331
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41843,0.00351042828481804,0.00372573001632907,-0.00379200254718694,0.010812859116823,0.346101194963211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41843,0.00174968149304491,0.00369910888959716,-0.00550057193056552,0.00899993491665534,0.636220398514159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41843,0.00217956875744388,0.00359308819513063,-0.00486288410501216,0.00922202161989991,0.544126529163626
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41843,0.00478414092994132,0.00384133106370334,-0.00274486795491723,0.0123131498147999,0.212992707795722
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41843,0.00450532101034523,0.00381362186550555,-0.00296937784604565,0.0119800198667361,0.237474637277517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41843,0.00470052665544813,0.00381159693319348,-0.00277020333361108,0.0121712566445073,0.217516652492799
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41843,0.00690676586161894,0.00378543112836572,-0.00051267914997787,0.0143262108732157,0.0680891900396753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41843,0.00822061642438203,0.00377784354516497,0.000816043075858694,0.0156251897729054,0.0295723059052341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41843,0.00553963560400625,0.0037792606966798,-0.00186771536148616,0.0129469865694987,0.142726863866868
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41843,0.00360044378780491,0.00382458287796609,-0.00389573865300863,0.0110966262286184,0.346519567569824
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41843,0.00629408044326726,0.00378388606119288,-0.00112233623667079,0.0137104971232053,0.0962579386247364
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23496.Total Lipids in Large VLDL,41843,0.00648630507703597,0.00377247702573758,-0.000907749893409693,0.0138803600474816,0.0855693632146967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23497.Phospholipids in Large VLDL,41843,0.00576640185217437,0.00384754839813802,-0.00177479300817616,0.0133075967125249,0.133969844111892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23498.Cholesterol in Large VLDL,41843,0.00804074271489142,0.00379927971216123,0.000594154479055405,0.0154873309507274,0.0343305883500907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41843,0.00930347035804486,0.00376993792091595,0.0019143920330496,0.0166925486830401,0.0136069938914
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41843,0.00651901506746319,0.00383544427113556,-0.000998455703962514,0.0140364858388889,0.0892152477224579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23501.Triglycerides in Large VLDL,41843,0.00599544479521582,0.00371957067898746,-0.0012949137355996,0.0132858033260312,0.107015208064092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41843,0.0111126102898195,0.00355518391936831,0.0041444498078576,0.0180807707717814,0.00177736725539476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41843,0.0103120583907284,0.00356728471462583,0.00332018035006174,0.017303936431395,0.00384972319133474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41843,0.0109848916825304,0.00354595053471158,0.00403482863449575,0.0179349547305651,0.00195325118366057
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41843,0.0113569257162082,0.00348288390053362,0.00453047327116235,0.0181833781612541,0.00111386134307834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41843,0.010868912527946,0.00347562062752137,0.0040566960980041,0.0176811289578879,0.00176870427270892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41843,0.0114500871207443,0.0035263103924844,0.00453851875147486,0.0183616554900137,0.00116900236680216
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41843,0.00754112542489902,0.00367189458958635,0.000344212029309776,0.0147380388204883,0.0400202262325871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41843,0.00992526362007926,0.00367713963083277,0.00271806994364703,0.0171324572965115,0.00695986747143873
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23510.Total Lipids in Small VLDL,41843,0.0101923830075814,0.00367903579110429,0.00298147285701702,0.0174032931581458,0.00560663422972369
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23511.Phospholipids in Small VLDL,41843,0.0111008983313059,0.0036016816163634,0.00404160236323364,0.0181601942993782,0.00205938015730098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23512.Cholesterol in Small VLDL,41843,0.0111754440653091,0.00363237015509323,0.00405599856132642,0.0182948895692919,0.00209784988650732
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41843,0.0107971016565082,0.00369865394261331,0.00354773992898616,0.0180464633840303,0.00351524719095591
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41843,0.0115774260435192,0.00353124556833614,0.00465618472958032,0.018498667357458,0.0010460453008974
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23515.Triglycerides in Small VLDL,41843,0.00682090841837997,0.00371817926261879,-0.000466722936352863,0.0141085397731128,0.0666058762427221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41843,0.0111587927144839,0.00351525744209672,0.00426888812797437,0.0180486973009935,0.00150496227647468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41843,0.0114447693000883,0.00354116316995859,0.00450408948696941,0.0183854491132071,0.00123260557999153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41843,0.0105015253268197,0.00353146856596534,0.00357984693752767,0.0174232037161118,0.00294763376315255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41843,0.0121829001754383,0.00356107702294813,0.00520318921045994,0.0191626111404166,0.000625503038216727
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41843,0.012279090379997,0.00358637495270116,0.00524979547270277,0.0193083852872913,0.000619352738819151
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41843,0.0114977146379052,0.0035319190638849,0.00457515327269077,0.0184202760031196,0.00113527881038568
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41843,0.00679628665220207,0.00361101090043636,-0.000281294712653197,0.0138738680170573,0.0598442340325728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23523.Concentration of IDL Particles,41843,0.00986002393891416,0.00348105942897531,0.00303714745812255,0.0166829004197058,0.00462584858377118
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23524.Total Lipids in IDL,41843,0.0127022839461909,0.00355377326884364,0.00573688833925739,0.0196676795531245,0.000352402778963979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23525.Phospholipids in IDL,41843,0.013014207732028,0.00355236485901111,0.00605157260836628,0.0199768428556898,0.000249729994661783
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23526.Cholesterol in IDL,41843,0.0121506736404939,0.00357305645544934,0.00514748298781322,0.0191538642931746,0.000674271785181148
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41843,0.0122067125996406,0.00357794476952631,0.00519394085136901,0.0192194843479122,0.000647628027046895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23528.Free Cholesterol in IDL,41843,0.0117725961298818,0.00354760271434002,0.00481929480977532,0.0187258974499882,0.000907576838304325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23529.Triglycerides in IDL,41843,0.00687766126926846,0.00348582282242955,4.54485373065543e-05,0.0137098740012304,0.048511983174482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23530.Concentration of Large LDL Particles,41843,0.0107343702856896,0.00344638300999086,0.00397945958610754,0.0174892809852717,0.00184539378725828
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23531.Total Lipids in Large LDL,41843,0.012127760139588,0.0034576042822259,0.00535085574642527,0.0189046645327508,0.000453732384107582
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23532.Phospholipids in Large LDL,41843,0.0116922310784006,0.00346873115471207,0.0048935180151649,0.0184909441416362,0.000751776427855992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23533.Cholesterol in Large LDL,41843,0.0120871323116702,0.00345964484434568,0.00530622841675266,0.0188680362065877,0.000477843212695009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41843,0.0120711237340909,0.00345405560050188,0.00530117475710723,0.0188410727110746,0.000476024812198887
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41843,0.0118928270073124,0.00349108686484395,0.00505029675221827,0.0187353572624066,0.000659667040770059
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23536.Triglycerides in Large LDL,41843,0.00647454197704738,0.00344373884222647,-0.000275186153716508,0.0132242701078113,0.0601176254694512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41843,0.0128877356665412,0.00347967532548009,0.00606757202860018,0.0197078993044821,0.000213325990653391
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23538.Total Lipids in Medium LDL,41843,0.0115843590920706,0.00345730222744504,0.00480804672627828,0.0183606714578628,0.000808348634487497
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23539.Phospholipids in Medium LDL,41843,0.0106432607758882,0.00347121281726052,0.00383968365405755,0.0174468378977188,0.00217271040544978
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23540.Cholesterol in Medium LDL,41843,0.0118965962167013,0.0034521035994782,0.00513047316172404,0.0186627192716786,0.000570319993873133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41843,0.0121260195755392,0.00346566207191517,0.00533332191458548,0.018918717236493,0.000468708507367336
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41843,0.0104674644488457,0.00343746446105718,0.00373003410517364,0.0172048947925178,0.00233050589652915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23543.Triglycerides in Medium LDL,41843,0.00600092295183174,0.00346883748888303,-0.000797998526378998,0.0127998444300425,0.0836621194244337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23544.Concentration of Small LDL Particles,41843,0.0107324379654914,0.00348490903161702,0.00390201626352208,0.0175628596674608,0.00207640747675201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23545.Total Lipids in Small LDL,41843,0.0108269083039825,0.00343466773969533,0.00409495953417961,0.0175588570737853,0.00162382596720223
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23546.Phospholipids in Small LDL,41843,0.0104453354531093,0.00342584385926346,0.00373068148895294,0.0171599894172657,0.00230071628479722
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23547.Cholesterol in Small LDL,41843,0.0110200314561533,0.00344399015556223,0.00426981075125134,0.0177702521610553,0.00137853805827408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41843,0.0109670282476154,0.00344569875223756,0.00421345869322977,0.017720597802001,0.00146186887378083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41843,0.00967910011662084,0.00344659089751822,0.00292378195748513,0.0164344182757565,0.00498749522182063
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23550.Triglycerides in Small LDL,41843,0.00529880494065113,0.00351578451295092,-0.00159213270473269,0.0121897425860349,0.131796772084657
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41843,0.0108425054219122,0.00401556307719631,0.0029720017906074,0.0187130090532169,0.00694023747568239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41843,0.008398573419743,0.00403094580542509,0.000497919641109828,0.0162992271983762,0.0372225907097539
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41843,0.00727609275384919,0.00401038661307301,-0.000584265007773905,0.0151364505154723,0.0696523154467455
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41843,0.00886710406990714,0.00407845209277611,0.000873337968065963,0.0168608701717483,0.0297126717059848
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41843,0.00942384643298408,0.00409861995043998,0.00139055133012172,0.0174571415358464,0.0215049256754998
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41843,0.00680381459635411,0.0039648971442424,-0.000967383806360998,0.0145750129990692,0.0861830717712718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41843,0.00787306673389549,0.0033576738803666,0.00129202592837696,0.014454107539414,0.0190520819488543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23558.Concentration of Large HDL Particles,41843,0.00836198221196597,0.00404541870087828,0.000432961558244547,0.0162910028656874,0.0387511704972501
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23559.Total Lipids in Large HDL,41843,0.00703975005136065,0.00401135151413001,-0.00082249891633417,0.0149019990190555,0.0792897579970075
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23560.Phospholipids in Large HDL,41843,0.0061658973600897,0.00397130809373463,-0.00161786650363018,0.0139496612238096,0.120539948283674
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23561.Cholesterol in Large HDL,41843,0.00712171998538252,0.00407393886447968,-0.000863200188997658,0.0151066401597627,0.0804670187397275
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41843,0.00685053424303041,0.00408871303940676,-0.00116334331420685,0.0148644118002677,0.0938647873286796
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41843,0.00781930719389735,0.00402496399761668,-6.96222414313472e-05,0.0157082366292261,0.0520732942653238
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23564.Triglycerides in Large HDL,41843,0.00771667002687432,0.00353355292015944,0.000790906303361831,0.0146424337503868,0.0289924109082485
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41843,0.00621917968764154,0.00370235415095904,-0.00103743444823819,0.0134757938235213,0.0930216527604847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23566.Total Lipids in Medium HDL,41843,0.00557252393093437,0.00364115096627508,-0.00156413196296479,0.0127091798248335,0.125934399501044
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23567.Phospholipids in Medium HDL,41843,0.00505635513147125,0.00358023881367996,-0.00196091294334148,0.012073623206284,0.157886471608323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23568.Cholesterol in Medium HDL,41843,0.00541368283964642,0.00374483429030254,-0.00192619236934655,0.0127535580486394,0.148301819956965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41843,0.00483462523634915,0.00374016739424665,-0.00249610285637427,0.0121653533290726,0.19616414021581
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41843,0.00756393084596502,0.00376056067098837,0.000193231930827812,0.0149346297611022,0.0443051539494873
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23571.Triglycerides in Medium HDL,41843,0.00520740494220291,0.00362777790210937,-0.00190303974593144,0.0123178496303373,0.151189498572683
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23572.Concentration of Small HDL Particles,41843,0.00679096816214424,0.00346319312915382,3.10962900276074e-06,0.0135788266952857,0.0499118604943297
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23573.Total Lipids in Small HDL,41843,0.00648178131621816,0.00346188504936295,-0.000303513380533215,0.0132670760129695,0.0611833781560648
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23574.Phospholipids in Small HDL,41843,0.00599324482188776,0.00344466810818829,-0.000758304670161285,0.0127447943139368,0.0819066022417938
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23575.Cholesterol in Small HDL,41843,0.00637885704071701,0.00344599517382473,-0.000375293499979452,0.0131330075814135,0.0641784458711591
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41843,0.00475716279943837,0.00346824390906543,-0.00204059526232987,0.0115549208612066,0.170200503622754
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41843,0.0100852688525872,0.00343391426887234,0.0033547968855974,0.016815740819577,0.00332017494108219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23578.Triglycerides in Small HDL,41843,0.00410187826369869,0.0039089662955614,-0.00355969567560165,0.011763452202999,0.294035683302051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,-0.00589965929532692,0.00394367557527509,-0.0136292634228661,0.00182994483221226,0.134683429403146
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,0.00227657256305942,0.00378862284961764,-0.00514912822219116,0.00970227334831,0.547919097066221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,0.00315190157666169,0.00383664855121552,-0.00436792958372073,0.0106717327370441,0.411362680505675
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,0.000735122953107888,0.00378479760399819,-0.00668308035072857,0.00815332625694434,0.845998505575675
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,-0.000519147231605778,0.00383445797127411,-0.00803468485530303,0.00699639039209147,0.892305655179334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41771,0.00269415219931562,0.00384388249428536,-0.00483985748948369,0.0102281618881149,0.483381872056159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41771,0.00322057524224072,0.00388636197186928,-0.00439669422262306,0.0108378447071045,0.407296909982381
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41771,0.00317311423993157,0.00386189724232934,-0.00439620435503393,0.0107424328348971,0.411293005311872
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41771,0.00403845963427159,0.00389849830766297,-0.00360259704874783,0.011679516317291,0.300267189088407
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41771,-0.00341414295324832,0.003871809134413,-0.0110028888566978,0.00417460295020116,0.377903625528211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41843,-0.00234623155707692,0.00400678314684399,-0.0101995265248911,0.00550706341073729,0.558177922199957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41843,0.00147689034474504,0.00374245296963372,-0.00585831747573705,0.00881209816522713,0.693121116214359
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41843,0.00282607465326241,0.00380652674458988,-0.00463471776613376,0.0102868670726586,0.457840811941639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41843,-0.00272889511087223,0.00379585558988695,-0.0101687720670506,0.0047109818453062,0.472206369480617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41843,-3.60790075763683e-06,0.00381606865957875,-0.00748310247353199,0.00747588667201671,0.999245654678607
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41843,0.00551572264323538,0.00367004458013951,-0.00167756473383806,0.0127090100203088,0.132887789134988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41843,0.00461756718458112,0.00380500340630948,-0.00284023949178546,0.0120753738609477,0.224940721059432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41843,0.00417346450444301,0.0038310255421781,-0.00333534555822607,0.0116822745671121,0.276003650422457
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41843,0.0059552415373969,0.00371939951316878,-0.00133478150841392,0.0132452645832077,0.109372016861422
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41843,-0.00481537307901628,0.00377158092125802,-0.012207671684682,0.00257692552664944,0.201712241397609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41843,0.00458324879139186,0.00370573480117497,-0.00267999141891108,0.0118464890016948,0.216183676292979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41843,0.00365270918249211,0.00357719854902963,-0.00335859997360597,0.0106640183385902,0.307221511980942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41843,0.00230601315119736,0.00352432640468577,-0.00460166660198674,0.00921369290438147,0.512921430770852
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41843,0.00544468074553384,0.00373791687477957,-0.00188163632903411,0.0127709978201018,0.145248243377953
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41843,-0.00397401423293488,0.00361343835045523,-0.0110563533998271,0.00310832493395737,0.271444723178516
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41843,-0.00541748300325093,0.00351041007440661,-0.0122978867490879,0.00146292074258603,0.122791076800795
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41843,0.00497028813713856,0.00370157753616369,-0.00228480383374228,0.0122253801080194,0.179376398561659
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41843,0.0051441490557114,0.00375317275847036,-0.00221206955089049,0.0125003676623133,0.170518718580151
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41843,0.00343184831107495,0.00326485471913457,-0.0029672669384288,0.00983096356057871,0.293209407512826
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41843,-0.00413388615776214,0.00365507843250303,-0.0112978398854681,0.0030300675699438,0.258076441982525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41843,-0.00192576015606658,0.00343262871409431,-0.00865371243569143,0.00480219212355826,0.574796017559096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41843,0.00451995699167772,0.0035982076496346,-0.00253253000160609,0.0115724439849615,0.209076854331362
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41843,0.00469412389756327,0.00354705832494501,-0.00225811041932896,0.0116463582144555,0.185730212954264
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41843,0.00210275511100584,0.00330000175809097,-0.00436524833485246,0.00857075855686413,0.52400677876222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41843,-0.00453022127521836,0.00362273677290458,-0.0116307853501113,0.00257034279967461,0.211140164056065
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41843,-0.00538172141393152,0.00350943810806086,-0.0122602201057308,0.00149677727786776,0.125176729604528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41843,0.00739765075644039,0.0035785471963738,0.000383698251547748,0.014411603261333,0.0387326430868367
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41843,0.00601804655154532,0.0034153592803678,-0.000676057637975559,0.0127121507410662,0.0780832879188183
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41843,0.00462389825081476,0.00384123562811169,-0.00290492358028414,0.0121527200819137,0.22870664310263
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41843,-0.00472883903925272,0.0035240907554558,-0.0116360569199461,0.00217837884144066,0.17966415892223
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41843,-0.0117191883917198,0.00360156418984877,-0.0187782542038233,-0.00466012257961618,0.00114111231834372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41843,0.0121968378390371,0.00355577345155661,0.00522752187398611,0.019166153804088,0.000605086344523431
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41843,0.0111289698925854,0.0036021234459367,0.00406880793854945,0.0181891318466213,0.00200869742648139
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41843,-0.00195911832197604,0.00371120881280843,-0.00923308759508056,0.00531485095112847,0.597582977740864
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41843,-0.00448331130273066,0.0035118660547916,-0.0113665687701222,0.00239994616466087,0.201759540963128
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41843,-0.00542214552808519,0.00358468766591303,-0.0124481333532747,0.00160384229710434,0.130408916968832
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41843,0.00716808920137333,0.00349470911881857,0.000318459328488935,0.0140177190742577,0.0402742958174836
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41843,0.00624009454028788,0.00355351603358156,-0.000724796885531983,0.0132049859661077,0.0791057378240528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41843,-0.00040702336552032,0.0035263822532033,-0.00731873258179878,0.00650468585075814,0.908112105863107
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41843,-0.00205648568485457,0.00358770347602301,-0.00908838449785967,0.00497541312815053,0.566516365355068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41831,0.00150032689234099,0.00382292959452922,-0.00599261511293628,0.00899326889761825,0.69472855837484
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41831,-0.00146828012767216,0.00332528616045369,-0.00798584100216139,0.00504928074681708,0.658822082995092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41831,0.00166703112907067,0.00309088064795677,-0.0043910949409246,0.00772515719906595,0.589662339607298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41831,-0.00830570100782395,0.00395964122570597,-0.0160665978102077,-0.000544804205440252,0.035960365614386
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41831,0.000755134465821608,0.00373735497849314,-0.00657008129202495,0.00808035022366816,0.839880346366131
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41843,-0.0085235254417092,0.00352795667661283,-0.0154383205278703,-0.00160873035554806,0.0157057207358936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41843,0.00372709689678281,0.00372457877572149,-0.00357307750363131,0.0110272712971969,0.317001717908695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41843,0.00218245051180944,0.0035827062107815,-0.00483965366132231,0.00920455468494118,0.54242713921521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41843,0.00744445708280802,0.00355557113161809,0.000475537664836562,0.0144133765007795,0.0363017242781228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41843,0.000874599281901383,0.00357637890546974,-0.00613510337281931,0.00788430193662208,0.806809576469957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41843,-0.00527967901095003,0.00381393804502917,-0.0127549975792072,0.00219563955730714,0.166286362380597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41843,0.000768214887375385,0.00381119207264884,-0.00670172157501635,0.00823815134976712,0.840257452458676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41843,-0.00179608924322664,0.00362175924488454,-0.00889473736320034,0.00530255887674707,0.619961734353915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41843,0.011492520885017,0.00395926624198815,0.00373235905072018,0.0192526827193137,0.00370583512922291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41843,0.0021758267830387,0.00375798617599052,-0.00518982612190272,0.00954147968798012,0.562607497665914
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41843,-0.00135798947865968,0.00348670782438859,-0.00819193681446132,0.00547595785714196,0.696930225881066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41843,3.69458890664836e-05,0.00345901671504406,-0.00674272687241987,0.00681661865055284,0.991478087594953
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41843,-0.00273391363172667,0.00340998796350744,-0.00941749004020125,0.00394966277674791,0.422719474505664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41843,0.0121781009258365,0.00369302872717091,0.00493976462058157,0.0194164372310915,0.0009777471337762
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41843,0.000988873115384056,0.00391391147263578,-0.00668239337098206,0.00866013960175018,0.800537993167007
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51406,-0.000559169363567445,0.0027751111241714,-0.00599838716694339,0.0048800484398085,0.840313801269682
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51406,0.000140585338104491,0.00269207973146806,-0.00513589093557291,0.00541706161178189,0.958352393839029
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49898,-0.000413582087057377,0.00257299473409521,-0.00545665176588399,0.00462948759176923,0.872300040709014
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49898,-0.000590411460884587,0.00280222685558535,-0.00608277609783187,0.00490195317606269,0.833128329846242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49898,-0.0019857102442703,0.00277488352151739,-0.00742448194644439,0.00345306145790379,0.474245418033605
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49898,0.000416418861497218,0.00255364168258083,-0.0045887188363612,0.00542155655935564,0.870465942606608
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24009.Traffic intensity on the nearest road,51406,0.00883850667033722,0.0731286212572027,-0.13449359099378,0.152170604334454,0.90380102408559
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24010.Inverse distance to the nearest road,51406,-0.00269565989847615,0.00242621549978544,-0.00745104227805562,0.00205972248110331,0.266556205267772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24011.Traffic intensity on the nearest major road,51406,-0.000977047091105545,0.00241888053500432,-0.005718052939714,0.00376395875750291,0.686271424754999
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24012.Inverse distance to the nearest major road,51406,0.00243999398844488,0.00245219887233728,-0.00236631580133619,0.00724630377822595,0.31973569261606
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24013.Total traffic load on major roads,51406,0.0503822245865584,0.0497495280965663,-0.0471268504827116,0.147891299655828,0.311205794949079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24015.Sum of road length of major roads within 100m,51406,0.0268464442657535,0.0488073108665102,-0.0688158850326065,0.122508773564113,0.582290706615818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51406,0.00033698657953802,0.00278939495547038,-0.00513022753318392,0.00580420069225996,0.903842657446597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51406,5.57498776799196e-05,0.00278888368196279,-0.00541046213896714,0.00552196189432698,0.984051498125996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51406,-0.000101714788020713,0.00275654245020134,-0.00550453799041534,0.00530110841437391,0.970565533723792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51369,0.00026862732617219,0.00269641572824852,-0.0050163475011949,0.00555360215353928,0.920643832539454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24020.Average daytime sound level of noise pollution,51406,0.000547359045660359,0.00242471783333546,-0.00420508790767715,0.00529980599899786,0.821404628331674
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24021.Average evening sound level of noise pollution,51406,0.000530727825287131,0.00242464030368101,-0.00422156716992765,0.00528302282050191,0.826738238380891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24022.Average night-time sound level of noise pollution,51406,0.000545527808450902,0.00242480552924926,-0.00420709102887765,0.00529814664577946,0.821998433542793
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51406,0.000508185217610762,0.00242475194063042,-0.00424432858602487,0.00526069902124639,0.833995525910284
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51406,0.000533194697507588,0.00242478133599343,-0.00421937672103954,0.00528576611605472,0.825955731845103
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2405.Number of children fathered,51400,0.0765159545894758,0.0400463151436838,-0.00197482309214449,0.155006732271096,0.0560574074648266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48958,0.0020796806639063,0.00288836043951333,-0.00358150579753984,0.00774086712535243,0.471520227238496
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48958,-0.00448336201723274,0.00259495541162235,-0.00956947462401255,0.000602750589547067,0.0840532109127328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24502.Water percentage, buffer 1000m",48958,0.00247991796119178,0.00262152635528075,-0.00265827369515849,0.00761810961754205,0.344168757999982
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48958,0.0034313025322082,0.00270916393971537,-0.00187865878963393,0.00874126385405033,0.205329285860784
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48958,-0.00470808251927641,0.00261611977349102,-0.00983567727531882,0.00041951223676599,0.0719317744434254
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24505.Water percentage, buffer 300m",48958,0.00364009808460036,0.00263428575281577,-0.00152310199091855,0.00880329816011927,0.167043381184141
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51486,0.000605096526485852,0.00276911145413935,-0.00482236192362728,0.00603255497659898,0.827028656867264
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51486,0.00138645717109737,0.00258917403518107,-0.00368832393785753,0.00646123828005226,0.592321516005731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24508.Distance (Euclidean) to coast,51486,0.00121820648462188,0.00245063848459365,-0.00358504494518169,0.00602145791442544,0.619125009277989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2867.Age started smoking in former smokers,35345,-0.00301119428085281,0.00465031931905879,-0.012125820146208,0.00610343158450241,0.517314777298412
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36832,-0.134192790588524,0.0817622909515661,-0.294446880853593,0.0260612996765459,0.100782648203489
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36831,-0.144763034133989,0.0949527443882916,-0.330870413135041,0.0413443448670625,0.127402372539224
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36831,-0.104341003266626,0.0867974511245889,-0.27446400747082,0.0657820009375684,0.229351400638015
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36821,0.00532011641238875,0.0813502517094661,-0.154126376938165,0.164766609762942,0.947858974635621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28739.Difficulty with standing for long periods,36838,-0.000267895165175469,0.0696860302198852,-0.13685251439615,0.1363167240658,0.99693277978328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28740.Difficulty with taking care of household responsibilities,36854,0.0464757338870611,0.0801135093016531,-0.110546744344179,0.203498212118301,0.561847140904403
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28741.Difficulty learning a new task,36806,0.0129472343109708,0.0947915897447695,-0.172844281588777,0.198738750210719,0.891361142885862
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28742.Difficulty with joining in community activities,36388,0.0132841903311675,0.0886825521849312,-0.160533611951298,0.187101992613633,0.880930346528108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28743.Difficulty with being emotionally affected by health problems,36800,-0.0150966168539902,0.0777438739878935,-0.167474609870262,0.137281376162281,0.846036618186256
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36860,-0.127968636108823,0.113730231097518,-0.350879889059959,0.0949426168423124,0.260539307975895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34754,0.0805448994394701,0.0733817138851061,-0.0632832597753378,0.224373058654278,0.272415415406814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2897.Age stopped smoking,35341,-6.59450229903878e-06,0.00487173540989217,-0.0095551959056877,0.00954200690108962,0.998920003984545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35913,-4.67152747115848e-05,0.0097116529300428,-0.0190815550175955,0.0189881244681723,0.996162138539699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35913,0.0106898058486171,0.0110021028560768,-0.0108743157492934,0.0322539274465276,0.331274356866835
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35913,-0.0673226274147175,0.0371210121631732,-0.140079811254537,0.00543455642510209,0.0697804683231638
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35913,0.00459447087199177,0.036409831448093,-0.0667687987662705,0.0759577405102541,0.899586860280082
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35913,-0.0391956089482456,0.0446708688043335,-0.126750511804739,0.0483592939082482,0.380281358233496
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35913,-0.0222674738182569,0.0403135808200234,-0.101282092225503,0.0567471445889889,0.58072091619548
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35913,-0.0189270442201703,0.016497419506552,-0.0512619864530121,0.0134078980126715,0.251306334979191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35913,0.00475382035157893,0.0309947098649694,-0.055995810983761,0.0655034516869189,0.878106619368382
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29002.Recent lack of interest or pleasure in doing things,35871,0.0961125062584244,0.0798983429420545,-0.0604882459080024,0.252713258424851,0.229040687170562
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29003.Recent feelings of depression,35872,0.0371471617052717,0.0807946450321516,-0.121210342557745,0.195504665968289,0.645693221524876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35876,-0.0543595236392674,0.0651369747363277,-0.18202799412247,0.073308946843935,0.40400318814168
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29005.Recent feelings of tiredness or low energy,35877,-0.0372716955089632,0.0629681870261096,-0.160689342080138,0.0861459510622115,0.553927166934909
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29006.Recent poor appetite or overeating,35883,-0.0830102756502164,0.108774789305809,-0.296208862689601,0.130188311389168,0.445405273341395
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29007.Recent feelings of inadequacy,35860,0.0314243534297131,0.0884021050859948,-0.141843772538837,0.204692479398263,0.722247361639259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29008.Recent trouble concentrating on things,35878,0.0052031479078493,0.0852643658227652,-0.16191500910477,0.172321304920469,0.95134200266858
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35876,-0.151859500403692,0.163096387495528,-0.471528419894927,0.167809419087544,0.351831299437902
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29010.Recent thoughts of suicide or self-harm,35856,0.0687638486933188,0.15532004060875,-0.23566343089983,0.373191128286468,0.657978865427859
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#0.Substances taken for depression_None of options listed,35800,0.00992856502760014,0.0189673724078089,-0.0272474848917053,0.0471046149469056,0.600673801131602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35800,-0.0191386731496772,0.0342944018790787,-0.0863557008326715,0.048078354533317,0.576814010975301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35800,-0.00386272823135284,0.0206681020584318,-0.0443722082658791,0.0366467518031734,0.851749617656802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35800,-0.0367196769333908,0.062638329528243,-0.159490802808747,0.0860514489419654,0.557747825307024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35800,-0.00307955922799045,0.040865834623586,-0.083176595090219,0.0770174766342381,0.93993213122121
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35800,-0.0593882026684989,0.0467847834660637,-0.151086378261984,0.032309972924986,0.204342524255929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35800,-0.088844682775572,0.0500404401903439,-0.186923945548646,0.00923457999750195,0.075864582953516
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35800,-0.0337494960961787,0.0585842411018186,-0.148574608655743,0.0810756164633858,0.56457581019813
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35800,0.0819899360233178,0.0405349287680924,0.00254147563785677,0.161438396408779,0.0431411420740633
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35800,-0.00146850129516138,0.0178092444906971,-0.0363746204969277,0.033437617906605,0.934285405532852
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35800,0.0512750434458343,0.0280515178231185,-0.003705931487478,0.106256018379147,0.0676076659581934
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35800,-0.0448790427222897,0.0457195893235848,-0.134489437796516,0.0447313523519364,0.32632245063025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35800,-0.100196426606651,0.0552915231799914,-0.208567812039434,0.00817495882613177,0.070004960606524
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35800,-0.0130330536923405,0.0331870855818527,-0.0780797414327717,0.0520136340480908,0.694541897157123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35800,-0.00737093921263064,0.0514745564086784,-0.10826106977364,0.0935191913483791,0.886139570323819
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35800,-0.0422330208878307,0.0520274892497105,-0.144206899817263,0.0597408580416019,0.416965170127738
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35800,-0.0192389847302466,0.0288040975881819,-0.0756950160030831,0.0372170465425899,0.504202703280602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35800,-0.0133659611186396,0.0272930645831706,-0.0668603677016539,0.0401284454643747,0.624346927672344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35800,-0.0674193071041795,0.0410949874304597,-0.14796548246788,0.0131268682595215,0.100929863904309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29058.Recent feelings or nervousness or anxiety,35765,-0.0763140662701041,0.0816701313119398,-0.236387523641506,0.083759391101298,0.350119653165551
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29059.Recent inability to stop or control worrying,35772,0.004464907774426,0.0833591498424076,-0.158919025916693,0.167848841465545,0.957285386000531
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29060.Recent worrying too much about different things,35771,-0.040645297400364,0.0757649159213765,-0.189144532606262,0.107853937805534,0.591653210187816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29061.Recent trouble relaxing,35767,-0.0383935358161369,0.0808025580876999,-0.196766549668029,0.119979478035755,0.634692778713657
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29062.Recent restlessness,35774,-0.105362384345463,0.11762441778052,-0.335906243195283,0.125181474504356,0.370414944566272
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29063.Recent easy annoyance or irritability,35763,-0.0602565238789123,0.0781270658829646,-0.213385573009523,0.0928725252516983,0.440576440554665
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29064.Recent feelings of foreboding,35766,0.00902856273786691,0.0942484538346057,-0.17569840677796,0.193755532253694,0.92368579737869
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35800,-0.0269136492824506,0.0223312014004436,-0.07068280402732,0.0168555054624188,0.228164236206618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35800,-0.0258096989107405,0.033676925545035,-0.0918164729790091,0.040197075157528,0.443468701312405
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35800,-0.000568621286635853,0.0472205555346306,-0.0931209101345118,0.09198366756124,0.990392585986439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35800,-0.0165803761507044,0.0464186564048767,-0.107560942704263,0.074400190402854,0.720958487667836
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#2.Symptoms of panic attack_Sweating,35800,-0.0288404904016885,0.0289162584689976,-0.0855163570009238,0.0278353761975468,0.318613738497694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35800,0.00572967090794608,0.0358925054336722,-0.0646196397420515,0.0760789815579437,0.873173725095818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35800,-0.00108125804085783,0.0342643288929898,-0.0682393426711179,0.0660768265894022,0.974826707743068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35800,-0.018409775425367,0.0346952921505038,-0.0864125480403545,0.0495929971896206,0.595703302760802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35800,-0.013595804806527,0.0435197193864564,-0.0988944548039815,0.0717028451909276,0.754741328827556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29076.Felt loved as a child,35734,0.0447634848972667,0.0646790928642224,-0.0820075371166091,0.171534506911143,0.488905951513289
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29077.Physically abused by family as a child,35747,-0.0614264427442674,0.0863990502539211,-0.230768581241953,0.107915695753418,0.477130985985595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29078.Felt hated by family member as a child,35740,0.0473430631166959,0.0909985967106831,-0.131014186436243,0.225700312669635,0.602897488645039
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29079.Sexually molested as a child,35724,0.0557414512685718,0.132171323489008,-0.203314342769885,0.314797245307028,0.673230201010776
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29080.Someone to take to doctor when needed as a child,35735,0.19704552481325,0.110736442845416,-0.0199979031637651,0.414088952790264,0.075215155559299
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35745,-0.112638134241224,0.156622888281733,-0.419618995273421,0.194342726790973,0.472061074377178
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35719,-0.29833603274907,0.14361396440125,-0.579819402975519,-0.0168526625226205,0.0378053188610524
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35756,-0.0557087731689905,0.14380644880531,-0.337569412827399,0.226151866489418,0.698481123367371
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35749,-1.13171441255058,0.59443781013051,-2.29681252040638,0.0333836953052222,0.0569711585691844
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35742,-0.0295099982456937,0.272468231641571,-0.563547732263173,0.504527735771786,0.913755849120135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29086.Experienced a violent or sexual assault,35762,0.00707410335189326,0.149241909174949,-0.285440038631007,0.299588245334793,0.962195553997709
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29087.Experienced a life-threatening injury or illness,35754,-0.0165902541361206,0.0722574003273604,-0.158214758777747,0.125034250505506,0.818409655382114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29088.Experienced a marital separation or divorce,35753,0.101428752577326,0.0703857120404683,-0.0365272430219915,0.239384748176644,0.149616654753688
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29089.Experienced the death of a spouse or partner,35763,0.18559207097126,0.0950005573270019,-0.000609021389663705,0.371793163332184,0.0507886853681418
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35757,0.0631750212130366,0.0862106806993174,-0.105797912957626,0.232147955383699,0.463705595085061
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29091.Frequency of drinking alcohol,35748,0.0738350374900218,0.059074580962734,-0.0419511411969369,0.189621216176981,0.211391124635772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35168,-0.0382672370069585,0.0610447244345889,-0.157914896898753,0.0813804228848357,0.530764849486399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35186,0.00103256994231604,0.0618351261881758,-0.120164277386509,0.122229417271141,0.986677442313893
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29104.Ever used cannabis,35744,0.0620617044067287,0.07773475759175,-0.0902984204731013,0.214421829286559,0.424677834574361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29108.Ever thought that life not worth living,35718,-0.0371042833026534,0.0813929125375645,-0.19663439187628,0.122425825270973,0.648500055857255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29109.Ever contemplated self-harm,35722,-0.057949467580182,0.119103350889028,-0.291392035322677,0.175493100162313,0.626593831289779
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29111.Ever self-harmed,35734,0.0130816477008724,0.204811183073874,-0.388348271123921,0.414511566525666,0.949074140130199
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35736,-0.332485792115825,0.146996522435756,-0.620598976089907,-0.0443726081417438,0.0237359163640209
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36383,-0.0425451892427225,0.0440488806783463,-0.128880995372281,0.0437906168868362,0.334142689863242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36383,0.0153638458009153,0.033926975606119,-0.051133026387078,0.0818607179889086,0.65066906364335
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36383,-0.0485433154208757,0.0428380593722484,-0.132505911790483,0.0354192809487312,0.257172760329248
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36383,-0.0507893946153272,0.0717958604315358,-0.191509281061137,0.0899304918304829,0.479330439201801
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35725,-0.0448833534419674,0.0684735599427245,-0.179091530929707,0.0893248240457725,0.512177064159347
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X29153.Pain or discomfort today,35740,0.0117497036442942,0.0606352582388414,-0.107095402503835,0.130594809792423,0.846356202596559
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29154.Anxiety or depression today,35740,0.0270090297004575,0.0811917377079567,-0.132126776207138,0.186144835608053,0.739402704641337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29166.Frequency of confiding in someone close,35568,0.000741162068785713,0.0605638256786995,-0.117963936261465,0.119446260399037,0.990236320535111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35723,0.00111396635600481,0.00921168044068736,-0.0169409273077424,0.019168860019752,0.903750076605213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35723,-0.000410999882487978,0.00952761645088441,-0.0190851281262214,0.0182631283612455,0.96559294079177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35723,0.0103184252279145,0.0101215774040731,-0.0095198664840688,0.0301567169398978,0.308024792536567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35723,-0.0239829692392711,0.0140533822100269,-0.0515275983709237,0.00356165989238158,0.0879470654028093
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35723,0.00790080070604634,0.0278807165827225,-0.0467454037960897,0.0625470052081824,0.776894803949368
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35723,0.00982674465953616,0.0102631932061945,-0.010289114024605,0.0299426033436773,0.338360362124701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35718,0.00675205747097195,0.0108065852834112,-0.0144288496845139,0.0279329646264578,0.532116102570092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35718,-0.0109631093323592,0.0169801187355935,-0.0442441420541224,0.022317923389404,0.518530840322926
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35718,0.00178786978555518,0.0194391966331876,-0.0363129556154926,0.0398886951866029,0.926722547534987
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35718,-0.0288610601166936,0.0235806997570023,-0.0750792316404181,0.0173571114070309,0.221020197512337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35718,-0.0118944415999607,0.038947181407776,-0.0882309171592016,0.0644420339592802,0.760070991576141
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35718,-0.000770928126517603,0.0156912563773828,-0.0315257906261879,0.0299839343731527,0.960816225994299
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29171.Frequency of feeling 'in tune' with people,35543,0.130638641371766,0.0806638175720834,-0.0274624410695178,0.288739723813049,0.105375585272814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29172.Freuency of feeling that lacks companionship,35679,0.0576850394674495,0.0698233409083096,-0.0791687087128374,0.194538787647736,0.408742903039051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29173.Frequency of feeling left out,35649,0.0615274954256879,0.0722695733628625,-0.0801208683655226,0.203175859216898,0.394597779905869
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29174.Frequency of feeling isolated from others,35682,0.0945631718852727,0.0732598537986228,-0.049026141560028,0.238152485330573,0.196818244453244
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29175.Tendency to bounce back quickly after hard times,35733,0.0570689636890538,0.0591321989893619,-0.0588301463300954,0.172968073708203,0.334523406804593
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29176.Ability to make it through stressful events,35733,0.00784931916275056,0.0594094839999366,-0.108593269477125,0.124291907802626,0.894891265853212
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29177.Quick recovery from stressful events,35733,0.0999666665541331,0.0602251274225721,-0.0180745831941082,0.218007916302374,0.0969819629639789
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29178.Hard to snap back when something bad happens,35733,-0.068225405447614,0.0591947024057834,-0.184247022162949,0.0477962112677214,0.249129952007293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29179.Comes through difficult times with little trouble,35733,0.0538313469727469,0.058647091994056,-0.0611169533356028,0.168779647281097,0.358709578874843
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29180.Tendency to take a long time to get over setbacks,35733,-0.0972201627052405,0.058638137495124,-0.212150912195683,0.0177105867852024,0.0973678908048517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29181.General happiness,35693,0.0134682537612358,0.0608011858058347,-0.1057020704182,0.132638577940672,0.824699386845598
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29182.Belief that own life is meaningful,35597,0.00858041128665229,0.0627883733263186,-0.114484800432932,0.131645623006237,0.891306601288732
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34686,-0.0681591977982375,0.0622996979747059,-0.190266605828661,0.0539482102321861,0.273974854401315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2946.Father's age,33423,0.00650479593248514,0.00836195534063817,-0.00988463653516567,0.022894228400136,0.436663948893661
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2966.Age high blood pressure diagnosed,35363,0.00180008933781524,0.00532719147809408,-0.00864120595924915,0.0122413846348796,0.735444602342164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30000.White blood cell (leukocyte) count,51051,-0.00070327386023263,0.00262315267086433,-0.00584465309512672,0.00443810537466146,0.788622863705654
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51052,0.0011050116971269,0.00282024176579849,-0.00442266216383813,0.00663268555809194,0.695198978329222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30020.Haemoglobin concentration,51052,0.00508790711075157,0.00296762806028839,-0.000728643887413676,0.0109044581089168,0.0864563770585654
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30030.Haematocrit percentage,51052,0.00373969478801807,0.00291281348781474,-0.00196941964809882,0.00944880922413495,0.199198179507402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30040.Mean corpuscular volume,51052,0.00376186425591292,0.00259804133408292,-0.00133029675888961,0.00885402527071545,0.147641735491173
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51052,0.00474568708470038,0.00260955288022139,-0.000369036560533545,0.0098604107299343,0.0689884733221915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51052,0.00279560376793787,0.00253502907998991,-0.00217305322884237,0.0077642607647181,0.270130355047907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51052,-0.000879112611364494,0.00265442391958259,-0.00608178349374637,0.00432355827101738,0.740505784625713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30080.Platelet count,51052,-0.00344660154441124,0.00259638523482184,-0.00853551660466204,0.00164231351583957,0.184369551105814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30090.Platelet crit,51052,-0.00376858905492634,0.00264526575484405,-0.00895330993442068,0.001416131824568,0.154271074082817
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51052,-0.000515138899645689,0.00245963931328498,-0.00533603195368425,0.00430575415439287,0.834109195336122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30110.Platelet distribution width,51052,0.0039903286595825,0.00252315414238933,-0.000955053459500596,0.00893571077866559,0.113781432129287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30120.Lymphocyte count,51015,-0.00172279913589854,0.00255425395039458,-0.00672913687867192,0.00328353860687483,0.500011676971341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30130.Monocyte count,51015,3.73288378730718e-05,0.00255318110798036,-0.00496690613376844,0.00504156380951459,0.988335057774397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30140.Neutrophill count,51015,-0.000697711443622934,0.00259451390800292,-0.00578295870330865,0.00438753581606278,0.787995274146048
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30150.Eosinophill count,51015,-0.00419616805029057,0.0024717734563476,-0.00904084402473186,0.000648507924150729,0.089590636477574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30160.Basophill count,51015,0.00641739554346807,0.0366417473577565,-0.0654004292777347,0.0782352203646708,0.860972070169508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30170.Nucleated red blood cell count,51015,0.0148886763907211,0.192605760720122,-0.362618614620719,0.392395967402161,0.938384543841341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30180.Lymphocyte percentage,51016,-0.000643263388907471,0.00252512122247784,-0.00559250098496404,0.0043059742071491,0.798921971395205
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30190.Monocyte percentage,51016,0.00172802010899766,0.00253051059904991,-0.00323178066514016,0.00668782088313548,0.494693468060068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30200.Neutrophill percentage,51016,0.000533391476689017,0.00248842133891303,-0.00434391434758052,0.00541069730095855,0.830276592430067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30210.Eosinophill percentage,51016,-0.00425466055418672,0.00244860330851217,-0.00905392303887058,0.000544601930497145,0.0822973981475715
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30220.Basophill percentage,51016,-0.00212134544860798,0.002557981094462,-0.00713498839375349,0.00289229749653753,0.406940908120223
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30230.Nucleated red blood cell percentage,51014,0.0305575121127756,0.189833968956216,-0.341517067041407,0.402632091266959,0.872118736494931
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30240.Reticulocyte percentage,50671,-0.000517731135095365,0.00269557665153496,-0.00580106137210389,0.00476559910191316,0.847691544731898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30250.Reticulocyte count,50671,-0.00031486516029724,0.0027189353420169,-0.00564397843065037,0.00501424811005589,0.907808475641054
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30260.Mean reticulocyte volume,50671,0.00206268119464365,0.00255239493151837,-0.00294001287113235,0.00706537526041966,0.419021239095091
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30270.Mean sphered cell volume,50671,0.0029992833489797,0.00256496157325423,-0.00202804133459859,0.00802660803255799,0.242283826073984
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30280.Immature reticulocyte fraction,50671,-0.00219715263973176,0.00265664529873362,-0.00740417742524965,0.00300987214578612,0.408223179300308
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50671,-0.00162147203454658,0.00273264420767185,-0.0069774546815834,0.00373451061249024,0.552938921715106
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30300.High light scatter reticulocyte count,50671,-0.00151071066176596,0.00274273034933171,-0.0068864621464561,0.00386504082292418,0.581772663378515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30500.Microalbumin in urine,36808,-0.00347290383898986,0.00374043358053088,-0.0108041536568304,0.00385834597885067,0.353187871177803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51102,0.00213080660989009,0.00274285435187168,-0.00324518791977841,0.00750680113955858,0.437251092660619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30520.Potassium in urine,51056,0.00455436710147543,0.00256066714156351,-0.000464540495989054,0.00957327469893992,0.0753211625993834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30530.Sodium in urine,51071,-0.000132372286539358,0.00264991882883821,-0.00532621319106225,0.00506146861798353,0.960160018043456
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30600.Albumin,48943,0.00743058002470845,0.00273538798707534,0.0020692195700408,0.0127919404793761,0.00660393552043428
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30610.Alkaline phosphatase,50625,0.000715963082435806,0.00266055525332423,-0.00449872521407968,0.00593065137895129,0.787853034527727
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30620.Alanine aminotransferase,50612,-0.00699159958754178,0.00287834309662063,-0.0126331520569182,-0.00135004711816534,0.0151469700809235
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30630.Apolipoprotein A,48882,0.00541943269122825,0.00293583624167113,-0.000334806342447166,0.0111736717249037,0.0649127535378749
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30640.Apolipoprotein B,50469,0.00698361326010082,0.00247274567904642,0.00213703172916982,0.0118301947910318,0.0047436585331543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30650.Aspartate aminotransferase,50547,-0.00755245853505419,0.00265282059792904,-0.0127519869069951,-0.00235293016311327,0.00441806738121091
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30660.Direct bilirubin,49094,0.00235368930804528,0.00273797297178229,-0.00301273771664802,0.00772011633273858,0.389993903804349
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30670.Urea,50609,0.00205658372807744,0.00260603309988561,-0.00305124114769836,0.00716440860385324,0.430025507798105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30680.Calcium,48936,0.00431088183892538,0.00270872166968506,-0.000998212633657333,0.00961997631150809,0.111516681497115
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30690.Cholesterol,50628,0.00981495996102643,0.00251068981232549,0.00489400792886847,0.0147359119931844,9.28532265164259e-05
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30700.Creatinine,50615,0.000460463295333924,0.00324730445263947,-0.00590425343183943,0.00682518002250728,0.887240370372788
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30710.C-reactive protein,50549,-0.0011319247090343,0.00278505851404446,-0.00659063939656144,0.00432678997849284,0.684432390027742
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30720.Cystatin C,50633,0.00195050759855214,0.00299999712448366,-0.00392948676543583,0.00783050196254012,0.515589310445468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30730.Gamma glutamyltransferase,50611,-0.00358991276422657,0.00303698948681298,-0.00954241215838,0.00236258662992687,0.237193492031533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30740.Glucose,48910,-0.0013658110720974,0.00257862757164159,-0.00641992111251492,0.00368829896832012,0.596349389963309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50534,-0.00659812870205407,0.00254105827161889,-0.0115786029144271,-0.00161765448968105,0.00942124919813469
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30760.HDL cholesterol,48922,0.00802739658412878,0.00305940330429502,0.00203096610771055,0.014023827060547,0.00870086054184889
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30770.IGF-1,50523,0.00149663124984332,0.00266988890516172,-0.00373635100427366,0.0067296135039603,0.575103682492604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30780.LDL direct,50577,0.00932086150471122,0.00250563305242914,0.00440982072195009,0.0142319022874723,0.000199747971078437
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30790.Lipoprotein A,46190,0.000187018086604929,0.0027876984342905,-0.00527687084460446,0.00565090701781432,0.946513273584389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30810.Phosphate,48883,-0.0035990119323079,0.00264345955793102,-0.00878019266585269,0.00158216880123689,0.173377816344133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30830.SHBG,48790,0.00655527152285898,0.00351957319633342,-0.000343091941954522,0.0134536349876725,0.062544500623315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30840.Total bilirubin,50529,0.0042909228208274,0.00274115289832007,-0.00108173685987994,0.00966358250153474,0.117510239547717
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30850.Testosterone,50398,0.00899925167473014,0.00430231113887351,0.000566721842538068,0.0174317815069222,0.036474667198326
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30860.Total protein,48913,-0.000769139347280112,0.00268907646981513,-0.00603972922811778,0.00450145053355755,0.774862958622971
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30870.Triglycerides,50601,-0.00160846238538733,0.00263331573174093,-0.00676976121959955,0.0035528364488249,0.541329971763619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30880.Urate,50598,0.000917249150332013,0.00315543785464052,-0.00526740904476341,0.00710190734542744,0.771292391973969
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30890.Vitamin D,49959,-0.00347016700400905,0.00279757070981533,-0.00895340559524709,0.00201307158722899,0.214833138731613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3137.Number of measurements made,49364,0.00804399631526052,0.0446319337562931,-0.079434593847074,0.0955225864775951,0.856974067232301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3143.Ankle spacing width,41696,-0.00247080416980196,0.00460467750008607,-0.0114959720699707,0.00655436373036673,0.591562928225895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41695,0.000840694372738347,0.00335788579189914,-0.00574076177938397,0.00742215052486066,0.80230964404265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3146.Speed of sound through heel,41696,0.000505335796817647,0.0032447802319212,-0.0058544334577479,0.0068651050513832,0.876241891520884
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41696,0.000604410797546123,0.00327504133637152,-0.00581467022174205,0.0070234918168343,0.853584404368761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3148.Heel bone mineral density (BMD),41677,0.000830554399168778,0.00329469330639615,-0.00562704448136767,0.00728815327970523,0.800976595555467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3526.Mother's age at death,42428,0.00056800416182196,0.00314400811445491,-0.00559425174250966,0.00673026006615358,0.856635193561536
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32860,0.00193387537275731,0.00588658595639212,-0.00960383310177124,0.0134715838472859,0.742532854286562
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4100.Ankle spacing width (left),35997,0.00183099432237251,0.00619451502016594,-0.0103102551171527,0.0139722437618977,0.767556732513841
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35995,-0.00187918988441311,0.00447289220921357,-0.0106460586144717,0.00688767884564548,0.674403726298694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4103.Speed of sound through heel (left),35997,-0.00121689764691903,0.00428322652743866,-0.0096120216406988,0.00717822634686074,0.77633579668293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35997,-0.00155722767309822,0.00434304405937131,-0.010069594029466,0.00695513868326956,0.719936954605139
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4105.Heel bone mineral density (BMD) (left),35988,-0.00210905431763959,0.00436100576845759,-0.0106566256238165,0.00643851698853729,0.628672400079042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35997,-0.00155330242293886,0.00434331489286506,-0.0100661996129544,0.00695959476707666,0.72062995960694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4119.Ankle spacing width (right),35986,0.0023122474194995,0.00606091556274907,-0.00956714708348869,0.0141916419224877,0.702842249795218
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35985,-0.00111581137446855,0.00450885052554496,-0.00995315840453667,0.00772153565559956,0.804550332803583
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4122.Speed of sound through heel (right),35986,-0.000755297292218476,0.00427418232262017,-0.00913269464455401,0.00762210006011706,0.859739829878746
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35986,-0.000996625343144595,0.00435033510972779,-0.00952328215821105,0.00753003147192186,0.818804044975362
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4124.Heel bone mineral density (BMD) (right),35975,0.000151607796575364,0.00436524518507458,-0.0084042727661708,0.00870748835932153,0.972295461522596
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35986,-0.000994462245419645,0.00435033400889535,-0.00952111690285454,0.00753219241201525,0.81919046083767
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4194.Pulse rate,36371,-0.00212251994590195,0.00400810090652293,-0.00997839772268689,0.00573335783088298,0.59643388658105
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4195.Pulse wave reflection index,36371,-0.00233174345854382,0.00420885670579442,-0.0105811026019009,0.00591761568481325,0.57958879578557
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4196.Pulse wave peak to peak time,36363,0.00103304601819496,0.00463817768726138,-0.00805778224883735,0.0101238742852273,0.823754077992037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4198.Position of the pulse wave peak,36371,0.000769637379949503,0.00501049566239991,-0.00905093411835432,0.0105902088782533,0.877925152281696
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4199.Position of pulse wave notch,36371,0.00234782134903696,0.00406230044874876,-0.0056142875305106,0.0103099302285845,0.563312162520885
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4200.Position of the shoulder on the pulse waveform,36371,-0.00110143742560181,0.0051054882831549,-0.0111081944605854,0.0089053196093818,0.829199229685584
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4269.Number of triplets attempted (left),36148,-0.349324698525968,0.121276166160673,-0.587025984200887,-0.111623412851049,0.00398282596518694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4270.Volume level set by participant (left),36060,0.0297271615069045,0.0563340272811948,-0.0806875319642372,0.140141854978046,0.597727028174188
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4276.Number of triplets attempted (right),36154,-0.311068065207018,0.122865377986669,-0.55188420606089,-0.0702519243531465,0.0113686626757636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4277.Volume level set by participant (right),36068,0.0415731925655035,0.0552585537027876,-0.0667335726919602,0.149879957822967,0.451870641858497
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4288.Time to answer,36331,0.000422613724122683,0.00477944262510866,-0.00894509382109029,0.00979032126933565,0.929542594069328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4290.Duration screen displayed,36331,-0.000117849607175211,0.00448502209474889,-0.00890849291288303,0.00867279369853261,0.979037668246654
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X46.Hand grip strength (left),51638,0.00200816525456649,0.00332482647342124,-0.00450849463333915,0.00852482514247213,0.545855575450292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X47.Hand grip strength (right),51639,0.00317885721234772,0.00327710284010618,-0.00324426435426039,0.00960197877895582,0.332046414943518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X48.Waist circumference,51693,-0.00915635540747252,0.00621958040316415,-0.0213467329976742,0.0030340221827292,0.14098531713017
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X4803.Tinnitus,36193,-0.115130539635428,0.0712458607268457,-0.254772426660046,0.0245113473891892,0.106144284447531
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4825.Noisy workplace,36265,-0.00423504639954749,0.0618596627648823,-0.125479985418717,0.117009892619622,0.94541952407727
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4836.Loud music exposure frequency,36220,-0.0383123437925273,0.0843128309944418,-0.203565492541633,0.126940804956579,0.649548834456889
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X49.Hip circumference,51687,-0.00154436389107667,0.00459392823608792,-0.010548463233809,0.00745973545165565,0.73674194833401
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X50.Standing height,51645,-0.0036833864432526,0.00347684060398177,-0.0104979940270569,0.00313122114055167,0.289425937277448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X5057.Number of older siblings,35349,-0.0127209055877322,0.0639428285650535,-0.138048849575237,0.112607038399773,0.842314213793253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X51.Seated height,51545,-0.0013974106950791,0.00302961993941212,-0.00733546577632684,0.00454064438616865,0.644623980738426
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5181.Ever had eye surgery,33820,0.0668605364213607,0.143804753160542,-0.214996779773302,0.348717852616023,0.641994051732794
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5186.Duration visual-acuity screen displayed (right),33809,0.000654717809822024,0.00491244058950487,-0.00897366574560753,0.0102831013652516,0.893979068037261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5188.Duration visual-acuity screen displayed (left),33805,-0.00429113493521153,0.00506111640506445,-0.0142109230891379,0.00562865321871478,0.39655308280323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5190.Duration at which refractometer first shown (right),33754,-0.00612981053189379,0.00506582746753411,-0.0160588323682607,0.00379921130447307,0.226322320115136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5193.Duration at which refractometer first shown (left),33750,-0.0042158985408275,0.00509503280114952,-0.0142021628310805,0.00577036574942555,0.408018871698309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5199.logMAR, initial (right)",33788,-0.00681655606749193,0.0751341275019946,-0.154079445971401,0.140446333836417,0.927714477919674
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5200.Final number of letters displayed (right),33788,-0.216807460042332,0.380373962055358,-0.962340425670833,0.528725505586169,0.568712549232206
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5201.logMAR, final (right)",33728,-0.00287521521725448,0.00488209318026049,-0.0124441178505651,0.00669368741605609,0.555933612140144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5202.Number of rounds to result (right),33788,0.0344999600407615,0.0707961819185226,-0.104260556519543,0.173260476601066,0.62605656679475
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5206.logMAR, initial (left)",33783,-0.0188646436953372,0.0747065191816524,-0.165289421291376,0.127560133900702,0.800651722727897
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5207.Final number of letters displayed (left),33783,0.0958622757756388,0.49004075218002,-0.8646175984972,1.05634215004848,0.844914471520154
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5208.logMAR, final (left)",33735,-0.000312046393974603,0.0049282565544793,-0.00997142924075403,0.00934733645280482,0.94951590128759
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5209.Number of rounds to result (left),33779,0.0166488599362941,0.0737217681865879,-0.127845805709418,0.161143525582006,0.821339692822902
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33587,0.00737307286843082,0.00484418554685043,-0.00212153080339603,0.0168676765402577,0.128060975577398
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33587,0.0087413691697681,0.00476377979211107,-0.000595639222769593,0.0180783775623058,0.0665704036256846
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5256.Corneal hysteresis (right),33587,0.00313750239114436,0.00494024671207793,-0.00654538116452839,0.0128203859468171,0.525398709197692
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5257.Corneal resistance factor (right),33587,0.00795600078393074,0.00488514735290384,-0.00161888802776079,0.0175308895956223,0.103458728417738
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33562,0.00622873791433419,0.00493610109457363,-0.00344602023103011,0.0159034960596985,0.207053419640754
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33562,0.00966467048964974,0.00487386646125218,0.000111892225595467,0.019217448753704,0.0474272172531484
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5264.Corneal hysteresis (left),33562,0.00752940895436911,0.00495184662448707,-0.00217621042962556,0.0172350283383638,0.128442676171142
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5265.Corneal resistance factor (left),33562,0.0117554558014853,0.00491778259671372,0.00211660191192643,0.0213943096910442,0.0168672139056323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34447,-0.354938617873392,0.403238086475976,-1.1452852673663,0.43540803161952,0.378775800491722
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51627,-0.0141527877482116,0.0135630418407354,-0.040736349756053,0.0124307742596298,0.29673614530934
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51627,0.00469972059396217,0.0157642414873739,-0.0261981927212908,0.0355976339092151,0.765610155856354
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51627,0.0396519305764153,0.0388007379578499,-0.0363975158209706,0.115701376973801,0.306821200875067
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51627,0.0082264020494122,0.00617014591403921,-0.00386708394210466,0.0203198880409291,0.182460040552863
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51627,-0.00580016562046935,0.00572387894598263,-0.0170189683545953,0.00541863711365661,0.310914263465667
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38690,0.00255792357169913,0.00714391608471891,-0.0114441519543499,0.0165599990977482,0.720308733123974
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38690,0.00773629980823285,0.0221911247620038,-0.0357583047252946,0.0512309043417603,0.727380873131689
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38690,-0.0144650924859986,0.0137684657337687,-0.0414512853241854,0.0125211003521881,0.293469424942758
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38690,0.00491759082773405,0.00830339842433355,-0.0113570700839597,0.0211922517394278,0.553704275279483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51695,0.0348763833277124,0.0130663290398637,0.00926637840957955,0.0604863882458452,0.00760898570564645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51695,0.0348763833277124,0.0130663290398637,0.00926637840957955,0.0604863882458452,0.00760898570564645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51695,-0.0108702018519799,0.00953538195095947,-0.0295595504758604,0.00781914677190069,0.254303959533409
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51695,0.0278297969531597,0.016775765428759,-0.00505070328720792,0.0607102971935274,0.0971437606641735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51695,-0.00551630858071523,0.0388083693031549,-0.0815807124148989,0.0705480952534684,0.886968893321461
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51695,0.00219914293503375,0.0278192221874625,-0.0523265325523927,0.0567248184224602,0.93699258253233
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51695,0.0264105546714883,0.0409266511335702,-0.0538056815503092,0.106626790893286,0.518729915328445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51626,-0.0101107100686674,0.00847067975346492,-0.0267132423854586,0.00649182224812383,0.232641840884825
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51626,0.00706327597903458,0.0150422625666619,-0.0224195586516227,0.0365461106096919,0.638672374053433
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51626,-0.00733479134606445,0.00776306102712664,-0.0225503909592327,0.00788080826710377,0.344754377236939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51626,0.00885276930638393,0.0114324135972819,-0.0135547613442886,0.0312602999570565,0.438727665299089
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51626,-0.00130694868291873,0.0115561608187986,-0.0239570238877641,0.0213431265219266,0.909955904182121
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51626,-0.00384966297571856,0.00651273952651348,-0.016614632447685,0.00891530649624786,0.554461007718338
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36935,0.003004219421948,0.0114740722870928,-0.0194849622607539,0.0254934011046499,0.79346146000155
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36935,-0.0056226522754585,0.0109406224595771,-0.0270662722962297,0.0158209677453127,0.607318506982148
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36935,-0.00729539346798908,0.0158693964189006,-0.0383994104490343,0.0238086235130562,0.645733067885923
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36935,-0.00829353596428708,0.0118930556828493,-0.0316039251026717,0.0150168531740975,0.485607780337586
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51574,0.00337368558871822,0.0230673056758381,-0.0418382335359244,0.0485856047133608,0.883722165822061
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51574,0.0142549525017372,0.0282296447206868,-0.0410751511508089,0.0695850561542834,0.613589010086882
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51574,-0.00906315920811755,0.0580492680309388,-0.122839724548758,0.104713406132523,0.875932914899927
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51574,-0.0042584559628132,0.0547062081045425,-0.111482623847717,0.10296571192209,0.937954191875634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51574,-0.0127657715321685,0.0215257252362538,-0.0549561929952259,0.0294246499308888,0.553155388267446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51574,0.0276065106203305,0.025361817359255,-0.0221026514038093,0.0773156726444704,0.276382855274867
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51574,0.00565019137618257,0.0106848022313691,-0.0152920209973009,0.026592403749666,0.596944893882089
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35471,0.000834707003447193,0.0179261782338908,-0.0343006023349787,0.0359700163418731,0.962862414068782
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35471,-0.00619190928902349,0.0176983769888047,-0.0408807281870806,0.0284969096090336,0.726456393763253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35471,-0.0220631620790673,0.02494093271651,-0.0709473902034268,0.0268210660452923,0.376394426369865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35471,-0.0136440593920936,0.00900076527193659,-0.0312855593250893,0.00399744054090213,0.129596280226255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38547,0.00728490649808333,0.00772348203378025,-0.00785311828812596,0.0224229312842926,0.345593691985335
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38547,-0.00242198131807999,0.00857188647944576,-0.0192228788177937,0.0143789161816337,0.77752815778891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38547,-0.00947347061996219,0.00757548267869136,-0.0243214166701973,0.00537447543027287,0.21113049122918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38548,0.0153104163463168,0.0175656724533692,-0.0191183016622868,0.0497391343549204,0.383442189766638
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38548,-0.00504510909825847,0.0105030603604402,-0.0256311074047212,0.0155408892082043,0.630991536497552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38548,-0.0101089286244243,0.0190775535890926,-0.0475009336590459,0.0272830764101972,0.596202796728883
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51626,0.00197018437957424,0.0168138742093712,-0.0309850090707934,0.0349253778299418,0.906721519648723
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51626,0.00107639464627453,0.0134593232211466,-0.0253038788671728,0.0274566681597219,0.936258704706951
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51626,-0.0183941763787715,0.0266820257519809,-0.0706909468526541,0.033902594095111,0.490588248784407
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51626,0.0103037035801836,0.0151630853505617,-0.0194159437069174,0.0400233508672846,0.496811769024228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51626,0.000276534573962715,0.0155658498388096,-0.0302325311101041,0.0307856002580295,0.98582610858109
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51626,-0.0200439674646707,0.0185915922065239,-0.0564834881894575,0.0163955532601161,0.280991499542682
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51626,0.00793215634547008,0.00541055791585807,-0.00267253716961174,0.0185368498605519,0.142647922838594
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34061,-0.0209140791135909,0.0143143409335409,-0.0489701873433311,0.00714202911614929,0.144057118956769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34061,-0.0204012487574163,0.0172098633909635,-0.0541325810037049,0.0133300834888723,0.235895372778245
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34061,0.0106985493050622,0.0127288934575523,-0.0142500818717403,0.0356471804818648,0.400668669703261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34061,-0.009001163766751,0.0112681535158567,-0.0310867446578302,0.0130844171243282,0.424432753838893
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51730,-0.00500321725075017,0.00657170094292705,-0.0178837510988872,0.00787731659738684,0.446469186189705
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51730,-0.00306237559172806,0.0214455931076583,-0.0450957380827384,0.0389709868992823,0.88645141026483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51730,-0.0107109228446655,0.00578489672462084,-0.0220493204249223,0.00062747473559133,0.064105756040956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51730,-0.00196392149367801,0.00540739362157827,-0.0125624129919714,0.0086345700046154,0.71646486660956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51730,-0.00948320457626435,0.00916909032711542,-0.0274546216174106,0.00848821246488186,0.30102640192286
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51730,-0.00537150124680644,0.00826289917892101,-0.0215667836374916,0.0108237811438787,0.51565046277047
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51730,-0.00896598369690596,0.00582897876938444,-0.0203907820848995,0.00245881469108754,0.124019750774623
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51730,-0.00891308534283034,0.0192569237253362,-0.0466566558444894,0.0288304851588287,0.643475565958174
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44708,0.00683121296731722,0.00585859807729067,-0.00465163926417248,0.0183140651988069,0.243625663441208
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44708,0.00687429785867472,0.00575523303459314,-0.00440595888912784,0.0181545546064773,0.232322309428268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44708,-0.0178333335645452,0.00745147521575552,-0.032438224987426,-0.00322844214166436,0.0167106809763135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44709,0.0225228513269827,0.0116542894421004,-0.000319555979534179,0.0453652586334995,0.053305417641381
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44709,0.000181077937870954,0.00657549075584793,-0.012706883943591,0.0130690398193329,0.978030721335714
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51510,-0.00940038939302177,0.0062400304711943,-0.0216308491165626,0.00283007033051906,0.131961555142356
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51510,0.00249873084211967,0.00489070535470231,-0.00708705165309686,0.0120845133373362,0.609416056593066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51510,-0.00365217590405516,0.00552567291300251,-0.0144824948135401,0.00717814300542976,0.508653069030786
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51510,0.00420649948814601,0.00846426952700453,-0.0123834687847829,0.0207964677610749,0.619214020958591
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51533,0.00233401034847779,0.00526499919336345,-0.00798538807051457,0.0126534087674702,0.657547964276936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51533,-0.000526168764588653,0.00734845129854298,-0.0149291333097329,0.0138767957805556,0.942918736181699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51626,0.00104370244009205,0.00536550170953299,-0.00947268091059261,0.0115600857907767,0.84576971661973
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51626,-0.00409892604574418,0.00673606075867621,-0.0173016051327496,0.00910375304126119,0.542858652882906
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51626,-0.00828621330389698,0.0143974444488364,-0.0365052044236163,0.0199327778158223,0.564936084901599
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51626,0.00824935783743126,0.013230001907763,-0.0176814459017842,0.0341801615766467,0.532939752214196
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51626,-0.0146259813784671,0.0159967912268105,-0.0459796921830157,0.0167277294260816,0.360565022764331
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51626,0.00290680017217608,0.0164480937215442,-0.0293314635220506,0.0351450638664027,0.859725440860463
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41696,0.000606626154902863,0.00327505596198494,-0.00581248353058763,0.00702573584039335,0.85305449217827
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X864.Number of days or week walked 10+ minutes,51266,0.0777369206053727,0.0338770764489113,0.0113378507655066,0.144135990445239,0.0217607861574158
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X874.Duration of walks,48680,0.00470559788791599,0.00253071993949692,-0.000254613193497968,0.00966580896932995,0.0629863516423254
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50682,0.01403794918232,0.0321303196422476,-0.0489374773164854,0.0770133756811253,0.662183347964585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X894.Duration of moderate activity,45992,0.0371166526380393,0.0387709095617162,-0.0388743301029244,0.113107635379003,0.338412752916392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X90087.No-wear time bias adjusted average acceleration,33204,1.14890492737473e-06,0.00516684661366346,-0.010125870457853,0.0101281682677078,0.999822591265291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50605,0.0631843633809985,0.0323812038256421,-0.000282796117260051,0.126651522879257,0.0510380078738585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X914.Duration of vigorous activity,41750,0.00133473564047526,0.00310107597444992,-0.00474337326944659,0.00741284455039711,0.666904117118215
